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ABSTRACT
Two functionsf helper and suppressor activity, 
of the thymus-derived lymphocyte (T-cell) in the humoral 
antibody response of rabbits to sheep erythrocytes (SRBC) 
were investigated. In the first aspect of this study 
splenic plaque-forming cell (PFC) and humoral' hemolysin 
responses to SRBC were examined in adult thymectomized, 
lethally x-irradiated rabbits infused with allogeneic 
bone marrow (BM) and thymus cells from cortisone- treated 
littermate donors. Seven to eight week old rabbits were 
thymectomized and at eight to ten weeks of age received 
900R total body x-irradiation. One portion of this group 
was infused intravenously (iv) with the total BM (B-cell 
source) and thymus cell populations from cortisone-treated
Qlittermate donors. Another group received *20 x 10 nucle­
ated BM cells. The remaining animals received no reconsti­
tuting cell populations. All groups were immunized iv with 
1.0 ml of a 10 percent suspension of SRBC. Peripheral white 
blood cell counts (WBC) and anti-SRBC hemolysin titers were 
determined on selected days after immunization. Represent­
ative animals from each group were killed on the seventh 
day after immunization and,their spleens were assayed for 
anti-SRBC PFC activity. Hemolysin responses in the BM re­
constituted and non-reconstituted animals were minimal 
when compared to the control group responses. Those animals
xiii
xiv
which received both EM and thymus cells showed a delayed 
but significant rise in hemolysin responsiveness which 
approached that of the normal control group. The PFC 
data reflected the hemolysin responses as the non-recon- 
stituted and BM reconstituted animals showed responses 
less than background. The infusion of BM and thymus cells- 
significantly restored the number of PFC (*1-8,3 per million 
cells) when compared to the normal control response (50.8 
per million cells). These data support the need for syn­
ergism between the T- and B-cell population in the humoral 
response to SRBC in rabbits.
In the second aspect of this study horse anti­
rabbit thymus gamma globulin (ATGG) was used to investi­
gate the suppressor function of the T-cell in antigenic 
competition between heterologous erythrocytes. Eight week 
old rabbits were injected iv with 1.0 ml of a 20# horse red 
blood cell suspension (2xHRBC) followed three days later 
with IxSRBC. ATGG was injected two days before, on the. 
same day and two days after HRBC injection (Test group).
The effect of ATGG was controlled by substituting normal 
horse gamma globulin (NHGG) or ATGG which had been adsorbed 
with thymocytes (ATGG-adsorbed control). An additional 
control group was injected with HRBC and SRBC only (compe­
tition) . Anti-SRBC PFC responses were assayed on the 5th 
day podt SRBC injection. The competition group showed a
supressed response (29 PFC/10̂ ) when compared to the 
normal non-competitive anti-SJRBC responses (72 PFC/10^). 
ATGG-treatment alleviated this antigen-induced suppression 
and these animals showed a marginally enhanced response 
(90 PFC/10^). The NHG6 and ATGG-adsorhed control groups 
were not significantly different from the competition 
group. The anti-SRBC hemolysin responses reflected the 
PFC data. These results suggest ATGG interfered with the 
suppressive effect of a priming injection of HRBC on the 




One of the major advances in immunobiology was the 
demonstration that there exists a dichotomy of function for 
immunocomp tent lymphocytes residing with two distinct 
lymphoid cell populations. It is generally accepted that 
both of these populations are derived from BM stem cells 
which differentiate to immunocompetence under distinct ana­
tomical influences. One cell type, the T-cell, differenti­
ates to maturity under the influence of the thymus and is 
responsible for the various aspects of cell-mediated-immun- 
ityi delayed-type hypersensitivity, homograft, mixed lympho­
cyte and graft-versus-host reactions. The second lympho­
cyte type, which also arises from the BM, does not come 
under thymus influence and populates ultimately specific 
anatomical sites in the peripheral lymphoid tissue distinct 
from areas populated by T-cells. This cell, known as the 
B-cell, is the precursor of the antibody producing plasma 
cell.
Recent research has revealed that differentiation 
of the B-cell to that of an immunoglobulin synthesizing 
plasma cell requires in most instances the simultaneous
1
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antigenic stimulation and differentiation of T- cells 
in an auxiliary or helper capacity. More recently it 
has become apparent that in addition to this well estab­
lished helper function, the T-cell may act under certain 
circumstances to suppress the immune response and that this 
suppressor function may be responsible for antigen-induced 
suppression observed in the phenomenon known as antigenic 
competition. It now seems that what at first appeared to be 
simple cooperation between a two cell system (T and B cells) 
in order to initiate antibody production in response to a 
specific antigen actually encompasses the expression of a 
regulatory function that activated T-cells may exert on anti­
gen stimulated B-cells. The following review is intended 
to present experimental evidence which support the existence 
of a regulatory role for the T-cell and also to elaborate on 
the nature and function of the two lymphocyte cell types.
Ontogeny of T and B Lymphocytes
Current evidence suggests that both the T and the 
B-cell arise from the same pluripotential stem cells (Figure 
1) which originate in the embryonic yolk sac and primitive 
blood islands and subsequently migrate to establish hemopoetic 
colonies in the fetal liver and bone marrow (Ford et al.,
1966| Owen and Ritter, 19691 Miller and Mitchell, 1969). 
Certain of these precursor cells migrate in turn to the par-
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Figure 1. Postulated roles played by the various 
lymphoid organs on the ontogeny and expression of the 
different lymphoid cell types.
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enchyma of the thymus which at that time consist of reticular 
epithelial cells derived emhryonically from the visceral 
pouches of the third and fourth pharyngeal clefts (Clark, 
1973). The epithelial cell compartment of the thymus report­
edly secretes glycoproteins, which have the ability to in­
duce T-cell development and maturation (Clark, 1968 & 19631 
White,1975l Goldstein,19751 Waksal et al., 1975). There is 
also some evidence that thymus influenced differentiation 
may continue after the T-cells exit this tissue and periph- 
eralize (Cohen et al., 1975).
In the avian system B-cell differentiation of the 
precursor stem cells has clearly been shown to occur in the 
bursa of Fabricius, a primary lymphoid structure (Glick et 
al., I9561 Warner et al., 1962). The tissue site for B-cell 
differentiation in the mammalian system has not been clearly 
elucidated, as a discrete organ of bursal equivalence has 
not been found. Hpwever, recent evidence indicates that the 
liver may, at least in part, be the site for B-cell differ­
entiation (Owen et al,, 197̂ 1 Cooper et al., 1975). It has 
also been suggested that the bone marrow is the mammalian 
analogue of the bursa of Fabricius and therefore the site of 
B-cell maturation (Claman, 1975).
T-Call Dependent Antibody Production
5
It is generally accepted that there are two dis­
tinct types of immunological responsiveness to antigen 
stimulation) cell-mediated-immunity (CMI) and humoral 
mediated immunity (antibody protein). When mice are neo- 
natally thymectomized (within 2k hours of birth) the T- 
cell population is effectively eliminated before it has 
an adequate opportunity to peripheralize (Takahasi et al., 
1970i Goldschneider and McGregor, 1966). As a conse­
quence of T-cell depletion, there is a concurrent loss in 
the ability to express CMI in the mouse (Papermaster et 
al., 1962) Miller, 1961 & 1962) Martinez et al., 1962) and 
in the chicken (Glick et al.,1956) Warner et al., 1962).
The absent thymocyte function can be restored with thymus 
grafts implanted in the thymectomized animal (Miller, 1961 
& 1962) Dalmasso et al., 19631 Taylor, 19631 Leuchars et 
al., 1965). Similarly bursectomy shortly before or after 
hatching will lead to severe impairment of the humoral Ab 
response, while leaving CMI response capabilities intact 
(Glick et al., 1956) Warner et al., 1962). Such investiga­
tions established that the bursal-derived lymphocyte was re­
sponsible for differentiation and maturation of the Ab pro­
ducing system and the T-cell for cell-mediated immunity.
Miller (1961 & 1962) complicated the picture when 
he showed that the depletion of T-cells by neonatal thymec-
tomy of mice resulted in a diminished humoral antibody res­
ponse when these animals were immunized with foreign serum 
proteins. This deficiency could be restored with thymus all 
ografts. This suggested a role for the thymus-derived lymph 
ocyte in humoral antibody responses. Miller et al. (196*0 
further implicated the T-cell in the humoral response by 
demonstrating that irradiated mice could be reconstituted 
to full immunocompetence with infusions of syngeneic BM, 
however, only if the recipient's thymus was present. Osoba 
and Miller (1963) showed that the immunological capacity of 
neonatally thymectomized mice could be partially restored by 
implanting thymus tissue enclosed in a Millipore diffusion 
chamber which prevented cell traffic into or out of the 
chamber, thus suggesting an endocrine function for the thy­
mus.
Some insight into the nature of the roles of the 
two cells was implied by the experiments of Kennedy et al, 
(1965) and Gregory and Lajtha (1968). Lethally irradiated 
mice received iv infusions of syngeneic lymphoid cells from 
various sources (ie. spleen, thymus, and BM) and then the 
recipient spleens were cut into thin serial slices 8 days 
after SRBC immunization. The spleen sections were assayed 
for hemolytic foci or clusters of antibody forming cells 
(Kennedy et al., 1965). Hemolytic foci were apparent only 
when recipients were reconstituted with spleen or lymph
node cells, but not when either BM or thymocytes were 
infused fclene. The data suggested that each cluster of 
AFC resulted from the activity of a single antigen react­
ive cell which had lodged in the recipient spleen, prolif­
erated and differentiated as a result of SRBC antigenic 
stimulation. The number of foci (cell clusters) increased 
linearly with the number of spleen cells transferred (slope 
of 1)i whereas, the number of individual PFC increased dis­
proportionately (slope of 2), which implied that the develop­
ment of a hemolytic focus was dependent upon the presence 
of one cell, while the AFC maturation or expression re­
quired the interaction of 2 cell types (Gregory and Lajtha, 
1968).
The first direct evidence for T-and B- cell syner­
gism was reported by Claman et al. (1966). These investi­
gators showed that optimum splenic hemolytic foci (Playfair 
et al., 1965 ) responsiveness could be restored in lethally 
x-irradiated mice by infusing both BM cells and thymocytes, 
but not when either population was infused alone. The quan­
tity of thymocytes or the BM cells infused was varied and 
the quantity of the ether cell population was kept constant 
(at optimal functional dose) and it was found that the num­
ber of hemolytic foci increased proportionally with the 
number of thymus cells infused. From this finding it was 
postulated that the BM cell constituted the source for the
AFC and that this cell population only expressed itself in 
the presence of an auxiliary cell of thymic origin.
This hypothesis was subsequently substantiated by 
others. Immunological responsiveness to SRBC was restored 
when neonatally thymectomized mice received either allo­
geneic thoracic duct or thymus lymphocytes (Mitchell and 
Miller, 1968). Thoracic duct cells appeared to be a better 
source for immunocompetent T-cells than the thymus, since 
thymocytes must first react with antigen before interaction 
and/or recruitment of BM cells for the production of anti- 
SRBC antibody. More significantly it was shown that in 
vitro PFC activity could be inhibited when treated with 
anti-H-2 sera directed against host, but not donor cells.
This latter observation proved the AFC was BM derived and 
the ARC was thymus derived (Miller and Mitchell, 1968 )•
The nature of the T-B cell cooperation was further charac­
terized with experiments which through the use of chromosomal 
markers showed that syngeneic or semiallogeneic T and B-cells 
would more effectively restore immunological responsiveness 
than allogeneic or xenogeneic T and B-cell combinations 
(Miller and Mitchell, 19681 Mitchell and Miller, 1968). It 
was further reported that lymphocyte populations were sens­
itive to 1000R in situ x-irradiation and importantly viable 
thoracic duct or thymus cells were required for successful 
immunological reconstitution (Miller and Mitchell,19681 
Claman et al,, 1968).
9
The need for a T-cell is not exclusive to the humoral 
response to heterologous erythrocytes since the majority of 
widely used antigens, for example serum proteins, are T-cell 
dependent (Taylor, 1969I Chiller et al., 1970» Miller and 
Sprent, 1971)* T-cells are also required to initiate humoral 
antibody responsiveness to defined hapten-carrier conjugates 
which has been adequately documented by several investigators 
(Katz et al., 19?0| Paul et al., 1970| Mitehison, 1969; 
Benacerraf et al., 1967). These hapten-carrier studies also 
further characterized the T-cell as a "helper” cell capable 
of carrier recognition (carrier specific) and the B-cell 
apparently exhibits or possesses hapten specificity. The 
development of in vitro lymphocyte culture methods by Mishell 
and Dutton (1967) and Marbrook (1967) made possible the in 
vitro demonstration of T and B-cell cooperation (Mosier and 
Coppleson, 1968; Munro and Hunter, 1970; Hirst and Dutton, 
1970; Schimpl and Wecker, 1971} Kettman and Dutton, 1971;
Katz et al., 1971).
Differential Characteristics of T and B Cells
In addition to the unique functional and maturational 
differences, there are a number of other markers and activ­
ities which can be used to select for or distinguish between 
T and B cells. A partial list of these characteristics is 
presented in Table 1.
Table 1. — Pertinent distinguishing features of B- and T-lymphocytes
Parameters B-lymphocytes T-lymphocytes
1. Surface Ag markers
2. Surface Ig determinants
3. Peripheral localization 





4. Functional sensitivity 
to x-irradiation
B-cell Ag
High density of Ig 
(10** molecules)





TL & Ly Ag 
Not really detectable 
(10* or absent)





with respect to 
helper function, 





5. Functional sensitivity 
to corticosteroids
sensitive (peripheral) 
resistant (marrow) sensitive population (95#)-cortical resistant population 
(5#) -medullary resistant population 
is capable of most 
T-cell functions
6. Response to Ag AFC (usually T-depend- 
ent)
not specifically invol­
ved in cell mediated 
immunity
ARC-recognition and binding of Ag, mi­
totic proliferation,, 
regulatory influence on B-cell but no Ab 
synthesis, cell med­iated immunity
7. Mitotic response tot Lipopolysaccharide and 
poke weed mitogen Phytohemagglutin and Concanavalin A
8. Antigen receptor fort Hapten Carrier
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Surface antigens. The bulk of the work done In 
the characterization of the variations in lymphocyte sur­
face antigens has been accomplished with the murine system. 
Mouse T-lymphocytes exhibit theta (£) and ]gr~ allo- 
antigens (Schlesinger and Yron, 1970i Raff and Wortis, 19701 
Kisielow et al., 1975)* The majority of the lymphocytes in 
the thymus of some inbred strains may also express a thymus 
lymphoma (TL-) antigen (Schlesinger* 1972). It is gener­
ally believed that the differences in surface antigens may 
represent the various stages of lymphocyte differentiation 
and transformation to immunocompetence under the influence 
of the thymus. The first step is most likely the commit­
ment of the stem cell to the obligatory level of the prethy- 
mic cell (Miller, 1975)* Under thymic influences* the pre- 
thymic cell undergoes transitional changes in surface antigens 
(Boyse and Old, 1969). The majority of the cells present in 
the thymus have a high concentration of 0 and TL-antigens 
and are not competent in initiating immunological events 
(Schlesinger, 1972). A minority of the thymocytes are immun­
ocompetent and are characterized by the loss of demonstra­
ble TL- antigen and a much lower density of 9-antigens, a 
property shared by the mature, peripheral, recirculating 
T-cells (Blomgren and Andersson, 1970).
T-cells can also be categorized on the basis of their 
longevity. Raff and Cantor (1971) distinguished thymus-
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derived lymphocytes as T-cells (short-lived with high 0 
antigen density) and Tg cells as long-lived with low 0 
activity. It was suggested that antigenic stimulation 
provoked the transformation of immature Tj cells into ma­
ture Tg cells which are responsible for all memory and ef­
fector functions. The concept of immaturity and immunocom- 
petence for the T̂  cell, however, has recently been quest­
ioned (Schlesinger, 1972i Shortman and Jackson, 197**-1 Cohen 
and Gershon, 1975)* Recent studies suggest that the T-cell 
antigens serve in a functional capacity to direct the "hom­
ing” characteristics and the responsiveness to mitogens ex­
hibited by the various T-cell subpopulations (Schlesinger et 
al., 1975).
B-lymphocytes are readily characterized by the pres­
ence of demonstrable membrane associated immunoglobulins 
(Raff and Wortis, 1970). These cell surface immunoglobulins 
have been shown to serve as receptors for the recognition of 
antigens (Sulitzeanu, 1971). Similar cell surface immuno­
globulins may also function as the carrier-recognition re­
ceptor on the T-cell, but are present in too few numbers to 
be readily detectable (Roelants and Ryden, 197*0. Distinct 
B-cell antigens, other than immunoglobulins, also have been 
identified on thymus-independent lymphocytes (Raff et al., 
1971i Laskov et al., 1973). There is also evidence for sub­
sets of B-lymphocytes, since plasma cells possess distinct
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antigenic determinants (Laskov et al., 1973) and there is 
evidence for short-lived (3-5 days) and long-lived (weeks- 
raonths) B-cells (Ropke et al., 1975)*
Antilymphocyte serum. Antilymphocyte serum(ALS) 
has been defined as the product obtained when lymphoid cells 
or lymphoid cell fractions from animals of one species are 
injected into an animal of another species. ALS has been 
used in vivo as an immunosuppressant for both CMI and humoral 
antibody responses and it appears to have a selective action 
on T-cells. The action of heterologous ALS has been equated 
with that of the more specific antisera to thymocytes (ATS) 
in that both seem to exert their effect primarily on the 
long-lived, recirculating T2 populations (Lance et al., 1973i 
Araneo, 1975). Heterologous anti-© antisera, on the other 
hand, seems to select for the short-lived T̂  population 
(Stobo and Paul, 1972) Olsson and Claesson, 1973)* ALS or 
antisera with narrower specificity (i.e., anti-©) can be 
used in vitro to characterize lymphoid tissues for the pre­
sence and position of T-cell populations by employment of 
either the complement-mediated cytotoxicity assay or the 
florescent label tagged antisera. Anti-immunoglobulin and 
anti-B-cell antigen anti-sera have been used similarly 
for the detection or elimination of B-cells (Kincade et 
al., 1970* Raff and Wortis, 1970).
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Susceptibility to x-irradiation. It has been 
known for some time that the immune system is particularly 
susceptible to irradiation* a fact Which* as discussed 
earlier has provided experimental models for adoptive trans­
fer studies. The capacity of host lymphocytes to engage in 
immunological activities is abrogated by irradiation* thus 
allowing for the immunological expression of infused donor 
cell populations. At first it was thought that both T and 
B-cells were equally radiosensitive* but it now has become 
apparent that the T-cell is functionally more resistant to 
x-irradiation than is the B-cell.
Katz et al. (1970) demonstrated that carrier-primed 
lymphocytes (T-cells) after having received high doses of in 
vitro x-irradiation were still capable of performing a helper 
function in enhancing secondary anti-hapten responses in syn­
geneic guinea pigs. The B-cells responsible for anti-hapten 
antibody production were, however, functionally destroyed by 
the same x-irradiation dose.
It was also reported that • educated" helper T-cells 
were radioresistant to high levels of x-irradiation and could 
initiate in vitro primary responses to SRBC or trinitrophenyl 
(TNP)-erythrocytes (Hirst and Dutton, 1970* Kettmann and 
Dutton* 1971). Exposure of carrier (SRBC)-primed spleen 
cells (mixture of T and B-cells) to high doses of in vitro 
x-irradiation abrogated their ability to develop an antibody
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response (B-cell), but did not affect their ability to 
act in helper capacity (T-cell) in the anti-hapten (TNP) 
response with normal spleen cells. It was further demon­
strated that this radioresistant helper cell was, in fact, 
a T-cell (Vann and Dutton, 1972). Observations of other 
investigators have been consistent with the interpretation 
of a radioresistant T-cell involved both in humoral (Munro 
and Hunter, 1970} Osaba, 1970) Goldie and Osaba, 1970}
Haskill et al., 1970) and cell-mediated immunity (Moller and 
Moller,1965i Asherson and Loewi, 1967t Feldman, 1968). It, 
therefore, seems likely that the expression of T-cell func­
tion does not require proliferation.
Corticosteroids. Like irradiation, cortisone has 
a general suppressive effect on immune responsiveness when 
administered in large doses to experimental animals. There 
is an .accompanying involution of the lymphoid structures, 
with the most obvious atrophy occurring in the thymus, where 
approximately 95% of the total thymic population is depleted 
by cortisone (Ishidate and Metcalf, 1963! Andersson and 
Blomgren, 197®). The cortisone resistant thymic population 
was shown to reside primarily in the thymic medulla, while 
the corticosteroid sensitive cells are found in the cortex. 
The cortisone resistant cells have been equated with the T2 
population and the sensitive cello with T̂  (Raff and Cantor,
1971).
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Levine and Claman (1970) reported that spleen cells 
from cortisone treated donors exhibited significantly less 
ability to adoptively transfer anti-SRBC responsiveness to 
x-irradiated recipients! whereas, BM cells from cortisone 
treated animals were perfectly capable of cooperating with 
thymocytes from non-treated animals. Further studies re­
vealed that adult thymectomized, irradiated, BM reconstituted 
mice could be restored to humoral antibody responsiveness 
with infusion of cortisone resistant, syngeneic thymus cells 
(Cohen and Claman, 19711 Andersson and Blomgren, 1971)* It 
was also shown that thymocytes from cortisone treated donors 
could restore the in vitro primary anti-SRBC response to a 
population of mouse spleen cells treated with anti-9 anti­
serum (T-cell depleted) (Schimpl and Wecker, 1971).
These experiments suggest that T-helper cells are 
functionally resistant to cortisone. B-cells which have per- 
ipheralized are cortisone sensitive! whereas, those which 
remain in the bone marrow compartment (stem cells) appear to 
be cortisone resistant. This resistence may be due to the 
fact that the drug-dose administered was too low to reach 
the sequestered cells in the bone marrow, rather than reflect­
ing a variation in sensitivities. Cortical T-cells are sen­
sitive to cortisone treatment and are presumably functionally 
immature with respect to helper function. Medullary T-cells 
are cortisone resistant and are apparently functionally immun-
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ocompetent and equivalent to the fully differentiated, 
peripheralized T2 population.
Helper Function (ARC) in Rabbits
Most of the work which established or assigned 
helper function to the T-cell has been done in either mice 
or rats. It has been suggested that in the rabbit the cell 
responsible for helper function may not reside in the thymus- 
derived population, but rather, in the bone marrow (Abdou 
and Richter, 19691 Singhal and Richter, 19681 Richter and 
Abdou, I969). These conclusions have been based on several 
different experimental approaches.
Singhal and Richter (1968) reported that, unlike 
that of other animal species, BM cells from normal adult 
rabbits were shown to respond with blastogenesis and tri- 
tiated thymidine uptake when incubated with various protein 
antigens in vitro 1 whereas, lymph node, spleen and thymus 
cells did not respond in the same manner. Mond and Thor** 
becke (1972) contradicted this study by demonstrating that 
normal mouse bone marrow gave a similar proliferate response 
to antigen as did normal rabbit bone marrow.
Abdou and Richter (1969) exposed nonthymectomized 
adult rabbits to 800R (surface incidence) total body ir­
radiation with a cobalt-60 source. This treatment destroy­
ed the capacity of these animals to produce splenic anti- 
SRBC PFC's upon immunization, however, responsiveness
could be restored to normal PFC levels by reconstituting 
these animals with normal allogeneic BM cells alone. They 
further reported that M/I cells from donors which had been 
immunized Zk hours previously with SRBC were unable to re­
store anti-SRBC responsiveness in x-irradiated recipients. 
From this the investigators concluded that the ARC is BM- 
derived and that they peripheralize subsequent to antigenic 
stimulation. Ozer and Waksman (1972) and Landry (197*0 
found that if a higher x-irradiation dose (900R mid-line, 
roughly equivalent to 1200R surface) were used, then recon­
stitution with a single cell population (BM, appendix or 
thymus) was not sufficient for restoration of anti-SRBC 
responsiveness, even when recipients received bone marrow
ocell infusion of 50 x 10 . Immune responsiveness could, 
however, be restored when thymectomized, x-irradiated recip­
ients received a combination of appendix cells and thymo-
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cytes which totaled 50x 10 cells (Ozer and Waksman, 1972). 
It was suggested that the lower irradiation dose used by 
Abdou and Richter was selectively depleting the B-cells 
while leaving the more radioresistant T-cell responsiveness 
intact.
Richter and Abdou (1969) further suggested that the 
AFC resides somewhere other than the BM and that the pre-AFC
Qpopulation is radioresistant. Bone marrow cells (5x 10 ) 
harvested from rabbits which exhibit one lymphoid cell
allotype were infused into irradiated (800R surface) recip­
ients which exhibit a different allotype, and the recipients 
were immunized with SRBC. The splenic PPC expression could 
be eliminated in vitro if the spleens were treated with 
antisera directed toward the recipient allotype marker* 
whereas no dimunition in splenic PFC expression was seen 
when anti-donor allotype serum was used. These data were 
interpreted and it was suggested that the ARC is present 
in the infused population of the donor BM cells and that the 
x-irradiated host provided the relatively radiation resist­
ant AFC.
The interpretation of the above may lose some valid­
ity in light of a recent report by Pilarski and Cunningham 
(1975). They found that lethally irradiated mice could 
mount a substantial immune response to heterologous RBC 
under certain circumstances. The response of the host, 
which may constitute 100# of the total response, occurred 
only if nucleated cells were transferred. It was optimal 
with low doses of BM cells (as opposed to spleen cells) and 
when suboptimal irradiation doses were used. These results 
suggest that a population of radiation-resistant B-cells 
exist which can be stimulated to both proliferate and syn­
thesize antibody in the presence of small numbers of nu­
cleated cells. Richter utilized both a low dose of irra­
diation (800R surface or bOOR midline) and a lower BM
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8reconstituting population (5 xlO BM cells) than Ozer and
oWaksman (900R midline and 50 xlO ). Therefore, the host 
immune response in Richter's experiments may actually re­
present the proliferation of a resistant B-cell population 
under the influence of viable nucleated BM infusions.
Evidence for a Suppressor T-cell Population
Various different experimental approaches have re­
vealed the probable existence of a lymphoid suppressor cell. 
Extensive studies concerned with antigen-induced-suppression 
(antigenic competition) have revealed the phenomenon to be 
suppressive rather than competitive in nature. Selective 
elimination of T-cells has shown that they may exert a 
suppressive effect which is most dramatic on studies done 
with T-independent antigens.
Antigenic competition. Antigenic competition is a 
phenomenon which can be expressed when one antigen upon in­
jection causes the suppression of the immune response to a 
second unrelated antigen. This phenomenon has recently be­
come more appropriately termed antigen-induced-suppression 
(AIS) (Kerbel and Eidinger, 1971). There have been and 
still are a number of different theories as to the immuno­
logical events surrounding AIS which have been thoroughly 
reviewed (Taussig,1972* Pross and Eidinger, 197̂ ). It is 
the intention of this author to deal primarily with the most
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widely accepted explanation as to how AIS occurs, namely 
T-cell induced suppression.
A number of parameters and conditions under which 
AIS may occur have been documented. It is generally ac­
cepted that AIS can be optimally evoked when (1) the two 
antigens (priming and test) are injected into the same 
site (Adler, 1957i Eidinger et al., 1971)I (2) the priming 
or suppressing antigen is given in a relatively higher 
concentration than the test or suppressed antigen (Brody and 
Siskind, 1969} Oukor and Dietrich, 1970; Eidinger et.al«, 
1971} Thorne, 1972)i (3) the priming antigen precedes the 
test antigen by one to seven days (Brody and Siskind,1972} 
Eidinger et al., 1968} Hanna and Peters, 1970} Moller and 
Sjoberg, 1970} Radovich and Talmage, 1967} Thome,. 1972), 
and (4) the priming antigen must be a T-dependent antigen 
(Eidinger et al., 1971} Moller, 19711 Sjoberg and Britton,
1972).
Radovich and Talmage (1967) first made the sug­
gestion that a soluble suppressor factor (secreted by 
sensitive T-cells) may be the vehicle responsible for anti­
genic competition. Horse erythrocytes (HRBC) were chosen 
as the priming antigen and sheep erythrocytes (SRBC) as the 
test antigen, since these two erythrocytes have been shown 
to lack common antigenic determinants and HRBC had been 
shown to markedly suppress the anti-SRBC response in mice.
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Lethally irradiated mice were reconstituted with varying 
doses of spleen cells from nonimmunized donors or from 
donors immunized with HRBC two days prior to transfer, and 
the recipients simultaneously immunized with SRBC. The 
spleens were removed from the recipients six days later and 
assayed for SRBC PFC numbers. It was found that as the 
spleen cell dose increased from the HRBC-primed donors, the 
splenic PFC numbers in the recipients decreased. On the 
other hand, an increase in the number of infused spleen 
cells from nonimmunized donors resulted in increased num­
bers of PFC in proportion to the number of spleen cells 
infused.
Similar results were obtained by Moller and Sjoberg 
(1970) and Waterston (1970) with HRBC-primed donor cells 
and a SRBC test antigen. By adoptive transfer of HRBC- 
primed spleen cells to irradiated mice followed several 
days later by SRBC immunization, it was shown that the num­
ber of ARC for SRBC responsiveness was not affected. How­
ever, when normal "non-primed" spleen cells were adoptively 
transferred to an irradiated recipient which had been pre­
viously primed with HRBC, there was marked suppression to 
SRBC given at the same time.
Brody and Siskind (1969) have studied haptenic com­
petition in rabbits. They observed that antigenic competi­
tion would occur even if the competing haptens were conjugated
to homologous or heterologous carrier molecules. This 
argued against the competition for a limited number of 
antigen sensitive cells (with mono specificity) and did 
suggest that hapten specific AFC were being suppressed.
They also reported that there was no change in antibody 
affinity which is in contrast to the nature of suppressed 
antibody responses observed during immunological tolerance 
where there is an obvious decrease in antibody affinity. 
They found that competition occurred only if the antigens 
were injected so that they came under the immunological 
influence of the same regional lymph nodes.
Fauci and Johnson (1971a)t in contrast, observed 
that the regional lymph node response to p-arsanilic acid- 
keyhole limpet hemocyanin (Ars-KLH) injected into the foot 
pads on one side of the experimental rabbit was markedly 
suppressed by the contralateral foot pads. They interpreted 
these data as evidence for a circulating inhibitory factor. 
They also showed that ip preimmunization with KLH (carrier 
alone) caused a marked suppression of the PFC responses to 
both Ars-KLH and TNP-KLH when injected into the foot pad 
three weeks later (Fauci and Johnson, 1971b). This finding 
is similar to the suppression observed in the "preemption" 
experiments reported by O’Toole and Davies (1971) during 
which the ip injection of SRBC caused a suppression in 
anti-SRBC responsiveness in the RLN draining the site of a
subsequent subcutaneous (sq) injection of SRBC.
Gershon and Kondo (1971a) clearly demonstrated that 
antigenic competition between SRBC and HRBC was thymus de­
pendent. Mice deprived of T-cells (adult thymectomized, 
irradiated, BM-reconsituted) were unaffected in their re­
sponse to HRBC after being primed with SRBC two to four 
days earlier. The reconstitution of these animals with 
graded doses of thymocytes revealed that the greater the 
number of T-cells infused, the greater antigenic competi­
tion to the test antigen. In a second study, Gershon and 
Kondo (1971b) demonstrated that antibody production to the 
priming antigen is not an important factor during antigenic 
competition. They showed that high titer anti-SRBC anti­
body infused into test animals in concentrations sufficient 
to suppress the antibody response to SRBC (primer Ag) would 
not alleviate the AIS of the test (HRBC) antigen.
Enhancement by depletion of T-cells. ALS (ATS) has 
been used to suppress the humoral response to a number of 
antigens (James, 1969i Lance et al,, 1973). Presumably, 
suppression occurs through the elimination of the helper 
T-cell necessary for antibody responsiveness (Martin and 
Miller, 1968). It has become apparent that there exists 
a group of antigens which are capable of provoking normal 
antibody responses even in the absence of T-cells. These 
antigens characteristically have molecular structure which
z$
consists of repeating identical haptenic units arranged 
in a linear sequence (Katz et al., 1969) and, in addition, 
humoral immune response to these antigens is characterized 
by, primarily, the IgM class of immunoglobulins (Britton 
and Moller, 1968* Katz et al., 1969)*
Baum et al. (1969) reported that rats pretreated 
with the IgG fraction of ALS showed a marked suppression 
of response to SRBC, however, the response to KLH was 16 
times greater than that of non-treated animals. During a 
study on the effects that T-cell depletion had on subse­
quent immunizations with various antigens, Kerbel and 
Eidinger (1971) reported similar results. They found, 
with ALS treatment or with ALS treatment in combination 
with adult thymectomy, that the antibody response to SRBC 
was suppressed 1 whereas, the response to either polyvinyl- 
pyrrolidine (PVP) or KLH was significantly enhanced. The 
enhanced PVP response continued through 25 days. The KLH 
response was enhanced through 15 days, but then began to 
show some suppression during the last 10 days. The enhanced 
anti-KLH response was restricted to IgM and the subsequent 
suppression occurred during the shift from IgM to IgG syn­
thesis. The response to PVP was entirely IgM. These data 
were interpreted to suggest that the early anti-KLH response 
was T-independent and like the response to PVP is normally 
suppressed by the T-cell population. The shift to IgG
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synthesis during the KLH response is dependent upon T-cell 
helper function which had been removed earlier.
Armstrong et al. (1969) similarly implicated the 
T-cell subpopulations playing a suppressor role since the 
response to thymus-independent antigens such as FVP or 
polymerized flagellin (POL) in T-cell deprived mice could 
be suppressed with the infusion of thymocytes. Baker et al.
(1970a) showed that the primary PFC response to pneumococcal
polyssacharide SSSIII (T-independent) could be enhanced 10- 
fold when the mice were treated with ALS. Enhancement could 
be suppressed by the infusion of thymocytes (Baker et al., 
1970b).
Okumura and Tada (1971a and 1971b) showed T-cell 
suppression of the horocytotropic antibody (HTA) response 
in rats immunized with DNP-Ascaris (As), (a T-dependent 
response). Adult rats which were thymectomized or splenec- 
tomized three to 10 days before primary immunization with 
DNP-As showed greatly enhanced and prolonged HTA titers
(Okumura and Tada, 1971a), If the rats were neonatally
thymectomized, they showed marked reduction in their ca­
pacity to develop anti-DNP HTA responses to DNP-As. Adop­
tive transfer of thymocytes from donors which had been 
hyperimmunized with As terminated the preexisting anti-DNP 
HTA production in recipients.
Biological nature of the T-suppressor cell. Two
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questions are currently being pursued by investigators 
interested in suppressor function. Is suppressor acti­
vity the function of a distinct subpopulation of T-cells 
or is it an antigen driven switch of helper function to 
suppressor function in the same cell? Is suppression 
mediated by some soluble factor or factors elaborated 
by T-cells or is there a requirement for cell-to-cell 
contact?
The bulk of current research in this area has 
indirectly supported the existence of a suppressor sub­
population in the T-cell compartment. When density puri­
fication with velocity sedimentation was used with spleen 
cells, a cell fraction was obtained which was strongly 
inhibitory toward the responsiveness of the other, normally 
responsive, spleen cell fractions to SRBC (Haskill et al., 
19711 Haskill and Axelrad, 1972). The suppressive function 
of this cell fraction was sensitive to treatment with anti- 
© and complement.
Dutton (1972) presented evidence which suggested 
that the mitogen concanavalin A (Con A) stimulates at least 
two different cell populations. The first cell was respons­
ible for an inhibitory effect on anti-SRBC responsiveness. 
This cell population was shown to be radiosensitive, short­
lived and sensitive to treatment with anti-6 antiserum 
characteristic of the Tj population as described by Raff
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and Cantor (1971). The other mitogen responsive cell 
population could not be identified on the basis of the 
data presented, but could be substituted for, and exhib­
ited the helper T-cell function in B-cell response.
Scavulli and Dutton (1975) selected for both the 
Con A-induced suppressor cells and the Con A-induced stim­
ulator cells. They found that spleen cells with inhibitor 
activity could be generated by incubating spleen cells in 
the presence of Con A for 48 hours followed by exposure to 
1000R irradiation. If the procedure were reversed and the 
cells were irradiated first and then incubated with Con A, 
a cell population with stimulator activity was selected for. 
Both of these populations were free of B-cell activity 
which had been eliminated by the irradiation step. Spleen 
cells were harvested from congenitally athymic (nu/nu) 
mice cultured and challenged with SRBC and the immunolog­
ical responsiveness was measured after the addition of 
varying numbers of stimulatory and/or suppressor cell pop­
ulations. It was found that suppressive effects could be 
reversed by the addition of stimulatory cells or by pre­
treatment of the inhibitor population with anti-T-cell 
serum and complement. These results are compatible and 
re-inforce the concept that two distinct populations of 
T-cells exist which mediate responsiveness either by stim­
ulation or suppression.
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Eidinger and Fross (1972) reported that suppressor 
cells were cortisone-resistant thymus cells which were sens­
itive to irradiation. In contrast Wsksler, Shell and Sis­
kind (197*0 reported that suppressor cells were cortisone 
sensitive and anti-thymocyte serum resistant. Cohen and 
Gershon (1975) have suggested that a cortisone-sensitive 
T-cell population may play a regulatory role on the highly 
reactive cortisone-resistant thymocytes.
Wu and Lance (197*0 have suggested that there ex­
ists a subpopulation of cells normally resident in the thy­
mus and spleen, but not in the lymph nodes, which can sup­
press the humoral response to SRBC. These T-cells are 
spleen-seeking and require the microenvironment of the 
spleen for the expression of their suppressive function. 
Their results further suggest that the suppressor cell is 
cortisone-resistant and relatively short-lived (two to 
four weeks).
Gershon et al. (197*0 also suggested an immuno- 
regulatory role for spleen-seeking thymocytes. These in­
vestigators examined the reaction (DNA synthesis) of infused 
parental thymocytes to the antigens in the spleen and lymph 
nodes of irradiated F̂  mice recipients. They removed the 
spleen-localizing fraction of thymocytes by splenectomizing 
recipients three hours after cell injection. Wih high 
thymocyte doses splenectomy resulted in elevated lymph node
response, which can be reversed (suppressed) by reinjec­
tion of spleen cells.
Kamin et al. (1972*) reported that the appendix as 
well as the spleen and Peyer's patches housed cells with 
suppressor activity, which could be eliminated by comple­
ment cytolysis in the presence of ATS. Suppressor acti­
vity could be enhanced by adsorption of the B-cells in 
the appendix to nylon wool columns thus enriching the T- 
cell population. They suggested that suppression may be 
one of the primary functions of the appendix in rabbits.
Suppressor T-cell function declined in NZB strain 
mice with age and these mice expressed an auto-immune 
disease more frequently with age (Barthold et al.t 197*0.
It was found that the T-independent PFC response to SSSIII 
increased with age in NZB micei whereas, there was no ap­
parent age associated increase in responsiveness observed 
in non-autoimmune BALB/c mice. The SSSIII response in 10 
month-old NZB mice could be suppressed by infusion of thy­
mocytes from four week-old NZB donors. Evidently, suppressor 
activity is a function of a separate T-cell subpopulation 
since the helper and effector functions in these mice were 
still apparent at two to three months, whereas suppressor 
function was absent. There was still a very high response 
to SRBC in four month-old NZB mice.
Thomas et al. (1975) characterized a soluble sup­
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pressor factor released by immune spleen cells in vitro.
The addition of low numbers of ovalbumin (OVA) immune 
spleen cells to SRBC-immune spleen cells (ISC) in a Mishell 
and Dutton (1967) tissue culture system reduced the number 
of anti-SRBC PFC in the presence of low concentrations of 
soluble OVA. The suppressor population was found to be 
irradiation sensitive (750R) and sensitive to the treat­
ment of anti-0 and complement. Inhibition would occur 
even when the two ISC populations were separated by a 
cell-impermeable membrane and the soluble inhibitor 
could be recovered from the chamber opposite the OVA-ISC 
system. The suppressor factor was shown to be sensitive 
to trypsin treatment and resistant to up to 70° C for 
30 minutes. In a sucrose gradient the M.W. was shown to 
be 55,000-60,000 daltons. This factor was distinct from 
the helper factor (Rubin and Coons, 1972} Gisler et al., 
1973i Schimpl and Wecker, 1972| Yu and Gordon, 1973) which 
had been shown to be sensitive to treatment at 70° C for 
30 minutes. Thomas et al. (1975) suggested that these 
factors are elaborated by separate T-cells since helper 
factor production was in part irradiation resistant, where­
as the suppressor factor function was irradiation sensitive. 
These findings further implied that cellular proliferation 
is required for suppressor factor, but not for helper fac­
tor production.
Chapter 2
MATERIALS AND METHODS 
Experimental Animals
Rabbits. Animals used in these studies were random­
ly bred, New Zealand White rabbits weighing 1.5-1.8 kilo­
grams (8-10 weeks old) obtained from a closed colony main­
tained in this laboratory. The rabbits after weaning were 
housed in stainless steel cages, fed Purina or Red Circle 
rabbit pellets and given water ad libitum.
Sheep. Pastured adult female western sheep from 
the LSU sheep farm (Ben Hur Road, Baton Rouge, La.) were 
used as red cell donors. Sheep blood was collected at 
approximately 4 week intervals from the jugular vein, into 
an equal volume of Alsever's solution (Campbell et al., 1963) 
and stored at 4° C until needed. The same red cell lotowas 
used for both immunization and for subsequent immunological 
assays.
Horses. Welsh ponies penned at the Diseased Ani­
mal Center on the LSU campus were used for both immunization 
in the production of anti-rabbit thymus serum and as red 
blood cell donors. Horse blood was collected at approxi­
mately 4 week intervals from the jugular vein into an
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equal volume of Alsever's solution and stored at 4° C 
until needed.
Erythrocyte Antigen
Preparation of the erythrocyte antigens. When 
needed, approximately 7 ml of RBC-Alsever's mixture was 
diluted to 15 ml with sterile 0,15 M NaCl (saline) or 
appropriate diluent and sedimented, in a 15 ml conical cen­
trifuge tube, at 1200 rpm for 10 minutes at 4° C in a model 
PRJ-refrigerated International Centrifuge (International 
Equipment Co., Needham, Massachusetts). The supernatant 
fluid and excess cells were aspirated by means of suction 
to the desired packed cell volume. The RBC sediment was 
washed three times with the appropriate diluent and finally 
resuspended to the desired concentration.
For immunization, a 10 percent suspension of SRBC 
and a 20 percent suspension of HRBC were prepared in sterile 
saline. One ml of the RBC suspension was injected iv via 
the rabbits' marginal ear veins.
Complement
Source and preparation of complement. Complement 
used in these studies was lyophylized guinea pig serum 
(Hyland Co., Division of Tratenol Laboratories Inc., Costa 
Mesa, California) obtained from the Baton Rouge General Hos­
pital serology laboratory. The reconstituted stock was
stored at -20° C in 1 ml aliquots in serum vials. Prior 
to use* the complement was thawed in an ice hath and dil­
uted at 4*° C in modified harbital buffer (Table 2) when 
used in serological assays or in Hank's balanced salt 
solution (HBSS, Table 3) when used for either plaque- 
forming cell determinations or cytotoxic assays.
Collection and Preservation of Rabbit Serum
A minimum of 3 ml of blood was collected from the 
central artery of the ear using a 22 gauge needle and a 
10 ml plastic syringe. The blood was allowed to clot at 
room temperature for 30 minutes, then freed from the tube 
by ringing the clot with a wooden applicator stick and 
stored at C. The serum was then decanted to k ml serum 
vials and stored at -20° C until needed for serological 
assay.
Serological Assay for SRBC Hemolysin Activity
Serum samples were thawed and the native complement 
activity was inactivated in a 56° C water bath for 30 min­
utes. Microtiter techniques and equipment (Cooke Engineer­
ing Co., Alexandria, Virginia) were used to determine hem­
olysin titers. U-shaped wells in the microtiter plates were 
filled with 0.025 ml of modified barbital buffer (Table 2) 
using a 0.025 ml micropipette. The 0.025 ml diluters were 
cleaned in distilled water, heated to incandescence, sub-
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Table 2.— Modified barbital buffer used in hemolysin 
microtiter assay of serum
Constituents Concentrationgrams/liter
5»5 Diethylbarbituric Acid 2.8750(Barbitali Veronal)
Sodium 5*5 Diethylbarbiturate 1.8750(Barbital sodiumi Veronal sodium)
Calcium chloride, dihydrate 0.1103
Magnesium chloride, hexahydrate 0.5083
Sodium chloride 4-2.5000
Procedure
Dissolve the barbital in 250 ml of hot distilled water 
(near the boiling point). Then successively add and 
dissolve the remaining reagents in the hot water.
Store at refrigerator temperatures. This is the stock.
For use dilute 1 part of the stock solution with k parts 
of distilled water and chill. The final pH of the 
buffer should be 7.3 to 7.4-. Prepare fresh dilution 
each week.
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Table 3.— Hank's balanced salt solution used in collecting 
and resuspendlng the cells for the PFC assays
Constituents
Flask 1. NaCl, 8 gi KC1, O.ifgi NagHPO^HgO, 0.189 gi 
KHgPO^, 0.05 gi glucose, 2 gj gelatin, 1 g in 
700 ml of boiled redistilled water.
Flask 2. CaCl2.2H20, 0.265 g in 100 ml boiled
redistilled water.
Flask 3. MgSOĵ , 0.09772 g in 100 ml boiled distilled 
water.
Flask if. NaHCÔ , 0.3^ g in 100 ml boiled redistilled 
water.
Procedure
1. Autoclave flasks 1, 2, 3, and if for 10 minutes.
2. When ready to use, mix the contents of flasks 2, 3, 
and if into 1.
3. Check pH (range from 7.2 to 7.6).
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merged in distilled water, and calibrated by blotting dry 
on a calibration blotter. The serum samples were drawn 
into the diluters by capillary action and the serum loaded 
diluters were placed in the first well of each respective 
row. The serum and buffer were mixed using a microtiter 
diluting handle and 0.025 ml of each dilution was carried 
to the second well of each row. This procedure was repeated 
through 12 wells or more, as the titer dictated, thus af­
fecting a two-fold serial dilution. Next 0.025 ml of a 0.5 
percent SRBC suspension was added to each well and mixed 
with the diluted sera by gentle tapping of the plates.
Stock complement was diluted It15 and added in 0.025 ml 
volumes to each well. After thorough mixing, the plates 
were recorded as the reciprocals of the greatest log2 di­
lution of serum which showed complete hemolysis.
Assay for Splenic Plaque Forming Cells (PFC)
Collection of spleen cells. Rabbits were ex­
sanguinated by cardiac puncture and death was insured by 
the injection of 30 ml of air directly into the heart. The 
peritoneal cavity was opened and the spleen was removed and 
trimmed free of excess connective tissue and fat. The or­
gan was immediately transferred to a stainless steel cup 
with a sieve insert with a maximum pore size of 7̂  micron.
The spleen was minced (to a single cell suspension) 
with scalpel blades to free individual spleen cells and
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these cells were washed with approximately *+0 ml cold 
HBSS through the sieve into a 250 ml beaker immersed in 
an ice bath. The lymphoid cell suspension was centrifuged 
in a thick-walled 40 ml centrifuge tube at 1200 rpm for 
10 minutes at 4°C. The supernatant fluid was discarded 
and the cells were resuspended in 15 ml HBSS, transferred 
to a 15 ml calibrated conical centrifuge tube and sediment- 
ed.
A 10# spleen cell suspension (volume/volume) which
Ocontained approximately 10 cells was prepared in HBSS 
(stock suspension) from which appropriate dilutions were 
made (Landry, 1974).
Modified method for enumeration of splenic PFC 
numbers. A modification of the direct PFC assay of Jeme 
and Nordin (1963) was used (Landry, 1974). Briefly a
Omixture of 0.05 ml of each spleen cell dilution (i.e., 10 ,
7 610 , 10 cells) and 0.05 ml of a 7.5# suspension of erythro­
cytes in 0.4 ml of tempered (45°C) 0.5# agarose was layered 
onto each quadrant of a Fyrex Petri dish cover precoated 
with 0.1# agarose. Next, the surface of the Petri dish was 
gently flooded with a 1/32 dilution of the stock guinea pig 
complement. The dishes were placed on trays, covered with 
aluminum foil to maintain humidity and prevent drying and 
incubated at 37°C for two hours. The plaques were counted 
under indirect lighting and the totals were corrected to
4-0
give the number of PFC per million spleen cells and per 
whole spleen (Landryf 197*0 .
Reconstitution Studies
X-irradiation Procedure. All x-irradiation 
studies were performed with a Phillips-Norelco x-ray machine 
housed in the Nuclear Science Department on the LSU campus. 
Rabbits were retained under the source with cloth restraints 
and their behavior was monitored during irradiation with 
closed circuit television. Animals received an internal dos­
age of 60 R per minute at a machine setting of 300 kv and 10 
mA through a 2 mm aluminum plate at a target distance of 55 
cm. This dose rate was previously determined using a "phan­
tom carcass" and a Victoreen monitor (Yictoreen Instrument 
Co., Cleveland, Ohio) as described by Landry (197*0*
Pre and post x-irradiation care of animals. Rabbits 
were injected intramuscularly (im) with 0.5 ml of antihis­
tamine (Inactihist L.A., 7.5 mg chlorpheiramine maleate, 
Diamond Laboratories, Inc., Des Moines, Iowa) at least 30 
minutes prior to irradiation and then were injected im with
0.4- ml Combiotic (200,000 units penicillin and 250 mg strep- 
tomycini Charles Pfizer and Co., Inc., New York, New York) 
immediately after x-irradiation. The antihistamine was 
necessary to prevent death apparently due to anaphylaxsis 
from non-specific release of histamine, which occurred in 
approximately 1 of *f rabbits about 90 minutes following
x-ray treatment.
Individual animals were placed in steam cleaned 
cages following x-irradiation.
Thymectomy. Rabbits which weighed between 1000 and 
1500 grams (approximately 7 to 8 weeks old) were more con­
ducive to successful thymectomy due to less vascularization 
of the chest, little or no fat in and around the thymus and 
enhanced post surgery recovery. The chest area was shaved 
from the neck to the epiphistemum using a staight-edged 
razor and soap. The area was then cleaned using Phisohex 
and water applied with a sterile gauze. One ml of 2.5 % 
sodium thiopental was administered iv and up to 2.0 ml was 
given throughout the surgical period as needed. An incis­
ion was made through the dermis and muscle layers to the 
immediate left of the sternum (as viewed from the anterior 
position) extending from the hyoid cartilage to the level 
of,, the fourth rib. The chest cavity was entered by cutting 
through the first and second ribs at their sternocostal 
junctions. The muscle layers were cut to the third rib and
the opening was gently retracted using stainless steel
spreaders. The thymus was removed in toto with dog-toothed
forceps from its position above the heart. By gentle pulling, 
the thymus could be separated from its attachment site on 
the aorta. The musculature and ribs were closed with a
single suture line of 0000 gut suture and the dermis was
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closed using either 7.5 mm surgical clips or 0000 silk or 
synthetic suture. The area was cleaned with Phisohex and 
the rabbits were given 0.4 ml Combiotic im. The rabbits 
were housed individually in steam cleaned cages and allowed 
to convalesce at least 7 days prior to further experimental 
manipulation.
Cortisone treatment of donors. Littermates of the 
thymectomized, x-irradiated rabbits, which also weighed be­
tween 1500 and 1800 grams, were injected intraperitoneally 
(ip) with 250 mg of hydrocortisone-21-acetate (Sigma Chemi­
cal Co., St. Louis, Missouri) suspended in 20 ml of sterile 
saline. Seventy-two hours later, these rabbits were sacri­
ficed by exsanguination and were used for bone marrow and 
thymus cell donors. Cortisone treatment destroys immature 
cortical thymocytes leaving the mature medullary T-cells 
intact (Andersson and Blomgren, 1970). This treatment 
effectively reduced the thymus cell population to less than 
10# that of an untreated rabbit. Cortisone treatment also 
destroys the peripheral bone marrow-derived cells (B-cells), 
but does not appear to significantly affect B-cells present 
in the bone marrow (Cohen and Claman, 19711 and Levine and 
Claman, 1970). In this manner a more effective mature T-cell 
population could be obtained without any obvious significant 
effect on the B-cell.
^3
Collection of Bone Marrow and Thymus Calls for Reconstitution
Collection and preparation of BM cells. In all ex­
periments littermates were selected for BM-thymus donor- 
recipient pairings and they were also matched with respect 
to sex. Never were the reconstituting cell, populations of 
several donors pooled. BM was collected from the femurs and 
the tibio-fibulae into tissue culture medium 199 containing 
500 units of sodium heparin and 10 mg of pancreatic deoxy­
ribonuclease I (Sigma Chemical Co., St. Louis, Missouri) per 
liter. This procedure was thoroughly discussed by Landry 
(1971*) and with the exception of the addition of DNAase the 
procedure was unchanged. The BM cells were counted in an
ohemocytometer and 20x10 nucleated cells in approximately 
6 ml of TCM 199 were infused through a 22 g needle into the 
marginal ear vein of the recipient at a rate of 3 ml per 
minute.
Thymus cell preparation for infusion. In all ex­
periments, if a recipient received both BM and thymus cell 
infusions, both cell populations were collected from the same 
donor. The entire rib cage was removed in order to expose the 
thymus, taking care not to nick any vessels. The trachea was 
then exposed above the heart, lifted with a dog-toothed for­
ceps and severed. The trachea was then lifted out of the 
chest cavity and by cutting the dorsal attachment sites the 
heart, lungs and thymus were removed. The heart was then
opened to drain the blood without contaminating the thymus. 
The thymus was then dissected free of the trachea and blood 
vessels and placed in a sterile Petri dish which contained 
20 ml of chilled TCM 199 containing heparin and DNAase on 
an ice bath. When chilled in this manner, the fat con­
gealed allowing the thymus tissue to be distinguihed from 
the fat which was then teased and dissected from the 
thymus and discarded. The thymus was then carefully minced 
with a curved scissors and forceps, freeing the thymus cells. 
The TCM 199 which contained the thymus cells was removed with 
a sterile Pasteur pipette and transferred to a 50 ml screw 
cap conical centrifuge tube. Fresh TCM 199 was added to the 
thymus tissue and the procedure repeated until 40 ml of 
thymus cell suspension had been collected in each of two 
centrifuge tubes. The tubes were shaken vigorously for 2 
minutes and centrifuged at 1200 rpm for 10 minutes at 4° C. 
This procedure further enhanced the separation of thymocytes 
from fat which could be removed from the top of the superna­
tant fluid. After the fat and supernatant fluid were de­
canted, the cells were resuspended in fresh TCM 199 and 
then passed once through a coarse stainless steel sieve 
and then through a fine mesh (74 micron) sieve to produce 
a single cell suspension. The resulting suspension was 
sedimented again in a sterile 40 ml centrifuge tube at 
1200 rpm for 10 minutes at 4° C. The supernatant fluid was
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aspirated, the cells resuspended in 15 ml of fresh TCM 199, 
transferred to a 15 ml conical centrifuge tube and centri­
fuged at 1200 rpm for 10 minutes. The cells were resus­
pended in 10 ml of TCM 199 and cell counts were made.
oThymus cell infusion. Rabbits were given 30 x 10 
normal thymus cells in the same manner as described for 
BM infusions.
When cortisone treated rabbits were used as the BM 
and T-cell donors the entire thymus cell population was
Q
mixed in 10 ml of TCM 199 with approximately '20 x 10 BM cells 
and this mixture was infused as previously described.
Experimental Pratoool
It had been previously determined that reconstitu­
tion with bone marrow cells alone did not restore immuno­
logical responsiveness to SRBC antigens in lethally x-irrad­
iated rabbits (Landry, 1974). The objective of one aspect 
of this study was to determine if infusion of thymus cells 
in conjunction with BM cells could restore immunological 
responsiveness. The experimental design is presented in 
Figure 2. Since the epithelial cell compartment of the 
thymus is not significantly affected by x-irradiation, it 
is conceivable that subpopulations of infused BM lymphoid 
cells could migrate to the thymus, differentiate and become 
mature, immunologically competent T-cells under the influ-
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ence of the reticuloepithelial structure (Katz and Benac- 
erraf, 1972). Therefore, to avoid this possibility, re­
cipients were thymectomized 1 week prior to x-irradiation 
and lymphoid cell infusion.
For almost 2 years all attempts to infuse thymus 
cells met with uniform failure due mainly to the presence 
of large numbers of lymphoid cells which never leave the thy­
mus. These cells are very fragile and when ruptured (i.e. 
during centrifugation) they release large amounts of nu- 
cleoproteins (Weir, 1973 )• These nucleoproteins aggregate 
during infusion and form emboli in the small capillaries 
which kill the rabbit, often before infusion of the thymus 
cells can be completed. In order to circumvent this prob­
lem, whole thymus implants and ip injections of thymus 
cells were attempted with little or no success. The 
addition of DNAase to collection, washing and infusion fluids 
made it possible to introduce thymus cells iv without the 
production of emboli. In later experiments cortisone was 
injected into the donors in an attempt to select for the more 
mature, competent T-cell population and in this way eliminate 
the immature T-cells (90%). The infusion of cortisone-re­
sistant T cells plus BM cells significantly reduced death 
due to embolism.
In all experiments representative animals were 
sacrificed 7 days following immunization with SRBC and their
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spleens were assayed for PFC numbers. Serum hemolysin 
titers were done for each experimental animal until sac­
rificed or on selected days 0 through 30 or until they 
died following exposure to x-irradiation and reconstitution. 
WBC counts per mar were done on blood samples taken on the 
2nd, 3rd, 4th, 5th, and 7th day post BM infusions (Figure 2).
Thymectomized. x-irradiated. BM infused, immunized 
rabbits. This experiment was designed to determine the 
capacity of BM cells to reconstitute immunological respons­
iveness to SRBC in thymectomized, lethally irradiated rab­
bits. Thymectomized, lethally irradiated (900R) rabbits0owere infused with 10 allogeneic (litter mate) bone mar­
row cells within 4 hours after x-irradiation. They were 
then immediately immunized with 1.0 ml of 10% SRBC.
Thymectomized. x-irradiated. BM and thymus infused 
immunized rabbits (T-X-BMT-I). In this experimental group 
the capacity of BM and thymus cells to reconstitute the im­
mune resposiveness to SRBC was examined. Thymectomized, ir­
radiated rabbits each received the total BM and T-cell pop­
ulation from one cortisone-treated donor litter mate within 
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II. Horse Anti-rabbit Thymo ŷfcft flamma Globulin Studies.
The purpose of the second aspect of this investi­
gation was to determine the effects, if any, on the in 
vivo administration of anti-T-cell antibody on the immuno­
logical resposiveness of rabbits to SRBC.
Preparation of horse anti-rabbit thymus serum(HARTS). 
Two Welsh ponies received at weekly intervals 3 iv injections 
of 3 x 1010 New Zealand White rabbit thymus cells suspended 
in 30 ml of HBSS (De La Nove, Koperstych and Richter, 1972). 
Two liters of blood were taken from the jugular vein on the 
2nd, 3rd and 5th week after the final thymocyte injection.
The serum was harvested as previously described and stored in 
50 ml aliquots at -20°C.
DEAE Fractionation of HARTS. The IgG fraction of 
horse anti-thymus serum has been reported to be as effect­
ive and less hazardous than whole serum or its ammonium 
sulfate fraction when used as an immunosuppressant during 
therapy treatment (Lance, Medawar and Taub, 1973). For this 
reason the IgG fraction, anti-thymus gamma globulin (ATGG), 
was used exclusively in these studies. Thirty g of DEAE 
Whatman DE 23 (Cat. No. 2̂ 233) was suspended in 800 ml of 
0.5 N NaOH and 0.5 M NaCl, stirred until bubbles were no 
longer apparent and allowed to settle for approximately 30
minutes. The supernatant fluid was decanted and the DEAE 
was resuspended in approximately 600 ml of 1 N NaCl. The 
suspension was stirred, allowed to stand for 30 minutes and 
the supernatant fluid decanted. The DEAE was washed with 400 
ml of 1 M NaCl and then filtered through two thickness of 
15 cm Whatman number 1 qualitative filter paper under nega­
tive pressure. Approximately 400 ml of 1 N HC1 was added to 
the DEAE and immediately filtered. The DEAE was rinsed once 
with distilled water, resuspended in approximately 700 ml of 
distilled water and allowed to stand for approximately 4 
hours at 4° C. The slurry was washed and filtered with dis­
tilled water until the pH of the filtrate was 7.0. The DEAE 
was next suspended in 1 liter of 0.01 M phosphate buffer pH 
8.0 (Table 4) and allowed to stand over night at 4° C. The 
slurry was stirred under negative pressure in order to re­
move trapped air. A glass column (20 x 400 cm) was filled 
by pouring the slurry down a glass rod into the column. The 
buffer was allowed to run through the column port as more 
slurry was added. After the column was filled, an addition­
al 200 ml of phosphate buffer was allowed to run through 
the column.
A 30 ml aliquot of thawed HARTS was heated in a 56 C 
water bath for 30 minutes (complement inactivation) and 
then adsorbed with thrice washed rabbit RBC (0.1ml packed 
cells/1.0ml serum) in an ice bath for 10 minutes to remove 
anti-rabbit RBC hemolysin. The serum-RBC suspension was centri-
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Table if.— Phosphate buffer used for the DEAE-chromato- 
graphy fractionation of horse serum to the IgG
component
Stock phosphate buffers
5 0̂ ml 0.5 M Na2HP0^
60 ml 0.5 M KHgPO^ 
pH 8.0
For fractionation or dialysist
20 ml of the stock is brought up to a liter 
with distilled water.
0.01 M phosphate buffer pH 8.0
For washing the columns
29 grams NaCl is added to each liter of 0.01 M 
phosphate buffer 
0.5 M NaCl in 0.01 M phosphate buffer pH 8.0
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fuged at 1200 rpm for 10 minutes and the serum was removed 
from the RBC sediment. The adsorbed serum was dialyzed at 
4 C against 100 volumes of 0,01 M phosphate buffer pH 8.0 
which was changed three times at 8 hour intervals. Next, 
the dialyzed serum was centrifuged at 3000 rpm for 30 min­
utes at ^ 0 to remove pseudoglobulih precipitate.
The buffer level in the column was allowed to en­
ter the DEAE bed and then 10 ml of dialyzed horse anti-serum 
was added, carefully, to the surface of the DEAE so as not 
to disturb the bed. The serum was allowed to enter the bed, 
and then the column was filled carefully with buffer. The 
buffer was allowed to flow from a reservoir through the 
column at a rate of 1-2 ml per minute. The eluant was col­
lected in 10 ml fractions. Optical density readings were 
made at 280 nm in a Beckman double beam spectrophotometer. 
All fractions with an 0.D, of 0.5 or greater were pooled.
The peak usually started after 50 ml had been collected (5th 
tube) and was generally complete within the next 30 ml (8th 
tube). These fractions were pooled and placed in dialysis 
tubing and concentrated from 30 to less than 10 ml by cover­
ing the tubing with polyvinylpyrrolidine or Aquaeide II 
(Calbiochem, La Jolla, California) at 4- C.
Total protein determinations were performed on the 
concentrated IgG sample by utilizing a modification of the 
Lowry method (Williams and Chase, 1971)* The total protein
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concentration of each IgG (ATGG) preparation was adjusted 
to 10 mg per ml by diluting with phosphate buffer and the 
molarity of the sample was adjusted to 0.15 with the addi­
tion of crystalline NaCl. Normal horse gamma globulin 
(NHGG) was prepared in the same manner as described for 
the immune serum described above.
Analysis of ATGG Fractions
ATGG was examined by immunoelectrophoresis against 
rabbit anti-horse whole serum in order to determine the 
homogeneity of the IgG fraction.
Preparation of rabbit antiserum to horse whole serum. 
Horse serum (HS) diluted li3 was emulsified in an equal vol­
ume of Freund's complete adjuvant (Difco Laboratories, De­
troit, Michigan). One ml of the emulsion was injected im 
into four sites in the upper hind legs of two rabbits. 
Thirty-six days later HS emulsified in Freund's incomplete 
adjuvant (Difco Laboratories, Detroit, Michigan) was injected 
into the rabbit by the same route. Seventy-four days after 
the first injection the rabbit received an iv injection of
0.5 ml of a 1>3 dilution of HS, 1.0 ml on day 75 and 2.0 ml 
on day 76. One week later serum samples were collected and 
used (rabbit anti-HS antiserum) in the immunoelectrophore- 
sis procedure.
Immunoelectrophoresis procedure (Oxoid Apparatus). 
Table 5 shows the material used in the electrophoresis pro-
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Table 5.— Reagents used for the electrophoresis of horse
serum and horse anti-rabbit thymocyte gamma globulin 
in gel and for the immunodiffusion and precipitation 
with rabbit anti-horse serum.
1. Stock barbital buffert
770 ml 0.1 M sodium barbital (20,6 g/l) + 230 ml 
0.1 N HC1
Ionic strength 0.077* pH 8.4
Stock buffer diluted ls2 for use in electrophoresis 
chamber and for agar preparation.
2. Agari
1,6% Noble agar in barbital buffer was used as 
experimental layer on slides.
0.2% Noble agar in barbital buffer used as adhesive 
layer on slides.
3. Solution used to stop pattern development!
2% NaCl in 0.05 M phosphate buffer (0.375 g KHoP0., and 12.6 g Na2HP0Zf.7H20 per liter) * *
4. Dye solutions




cedure. A thin layer of adhesive agar was applied to pre­
cleaned glass slides using a piece of filter paper as a 
brush. The agar was dried at 100° C for 5 minutes. A 1,3 
mm experimental agar layer was prepared on each slide by 
applying melted agar (80° C) to the slides with a warmed 
pipette (2.5 ml per slide). The wells (1 mm in diameter) 
and trough (2 mm in width) were cut in one operation with 
a gel punch and the agar plugs were removed from each well. 
Undilute samples of HS and ATGG were delivered to the outer 
wells on the same slide. The slides were placed in the 
electrophoresis chamber and wicks consisting of two layers 
of 3 MM filter paper were set in place. Blectrophoresis was 
accomplished in 90 minutes with a voltage gradient of 6 
volts per cm. The agar was then removed from the longi­
tudinal trough and undilute rabbit-anti-horse-serum anti­
serum waĵ 'added with the aid of a three ml syringe and 25 
gauge needle. The slides were allowed to develop in a hu­
mid environment at room temperature for 2k hours. Next the 
slides were placed in stopping solution (Table 5) for 72 
hours with several changes. Next the slides were washed 
in several changes of distilled water over a 2k horn: period. 
The wells and trough were then filled with water and a piece 
of moist filter paper was placed over the agar and the slide 
was placed in a 37° C incubator until the agar had dried to 
a thin film. The dried slides were placed in the dye sol-
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ution (Table 5 ) for three hours and decolorized with 2J6 
acetic acid until the background gel was clear. After 
a final wash in distilled water the slides were air dried.
Photographs were made by using the slide as a nega­
tive. It was placed directly in the enlarger head of a 
Beseler enlarger with 80 mm lens. Ilford no. 4 glossy 
paper was exposed for 10 seconds at a lens opening of f22, 
followed by development in the Ilford machine.
Cytotoxic assays of ATGG fractions. Cytotoxic 
assays were performed according to the method of DeLaNove, 
Koperstych and Richter (1972). A serial two-fold dilution 
of ATGG was made in HBSS and 0.1 ml of each dilution was then 
transferred to duplicate rows of Kahn tubes (10x75 mm). A 
0.1 ml suspension, which contained 2-3 x 10̂  normal viable 
thymocytes per ml, was added to each of the tubes, followed 
by 0.1 ml of a 1/5 dilution of stock complement. Control 
tubes were set up in a similar manner except that normal 
horse gamma globulin (NHGG) was substituted for ATGG. Addi­
tional controls consisted of duplicate tubes containing 
a) 0.1 ml of ATGG diluted 1/2, 0.1 ml of test cells and 0.1 
ml of HBSS b) 0.1 ml test cells, 0.1 ml of complement and 
0.1 ml of diluent c) 0.1 ml of NHGG (1/2), 0.1 ml test 
cells and 0.1 ml diluent d) 0.1 ml test cells and 0.2 ml of 
diluent. All tubes were incubated at 37° C in a water bath 
for one hour. Next all the tubes were immersed in an ice
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bath to stop the action of complement. One tenth ml of a 
trypan blue solution (4 parts 0.2% trypan blue stock and 1 
part 4.25% NaCl stock) was added to each tube. The trypan 
blue reagent was prepared from stock solutions immediately 
before needed.
The proportion of stained (dead) or unstained (live) 
cells was determined by the microscopic examination of 200 
cells in a Bright-line hemocytometer under the high, dry ob­
jective of a light microscope. Cells were examined two min­
utes after addition of trypan blue. The cytotoxic index of 
ATGG was calculated from the following formula *
Cytotoxic index* x 100
where DE represents the percentage of dead cells in the tube 
which contained ATGG dilutions and complement; and DC repre­
sents the percentage of dead cells in control tubes which 
which contained NHGG and complement. Cytotoxic indices for 
each ATGG preparation were calculated as the dilution of a 
10 mg/ml preparation which produced 50% cytotoxicity (cell 
death) of normal thymocyte target cells.
ATGG administration. ATGG was injected into the mar­
ginal ear vein as 30 mg doses in approximately 2 ml volumes.
Adsorption of ATGG with thymocytes■ Thymus cells 
were harvested as previously described and divided into ali­
quots which gave a packed oell volume of 0,4 ml in e&oh of
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four 15 ml conical centrifuge tubes. Approximately 90 mg 
of ATGG contained In 6 ml was mixed with one aliquot of thy­
mus cells. This mixture was Incubated with occasional shak­
ing for 30 minutes at 37° C in a water bath. The suspension 
was then centrifuged at 1200 rpm for 10 minutes. The super­
natant fluid (ATGG) was then mixed with a second aliquot of 
T-cells and treated as above. This procedure was repeated 
two more times and then a cytotoxicity index was determined 
on the adsorbed ATGG in order to determine the efficiency of 
the adsorption procedure.
Immunization schedule for antigenic competition 
studies. One ml of a 20% suspension of HRBC was injected 
iv followed 3 days later with an iv injection of one ml of 
a 10% suspension of SRBC. This regimen of antigen admin­
istration was previously shown to produce an optimal HRBC 
induced suppression of the immunological response to SRBC 
in the rabbit (Thorne, 1972),
Experimental Protocol
Experimental group I. This experiment was designed 
to determine the schedule of ATGG administration which would 
best exhibit optimal suppression of the anti-SRBC response. 
The IX group of animals received a single injection of 30 
mg ATGG two days prior to SRBCi the 2X group received two 
30 mg injections of ATGG, two days prior to and on the same
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day as SRBC challenge, and the 3X group received three 
injections of ATGG, two days before, the same day and two 
days after SRBC immunization. Serum samples were taken 
from each animal and serologically assayed for SRBC hemol­
ysins .
Experimental group II. This experiment was de­
signed to. determine the effect of 3xATGG treatment prior to 
SRBC immunization. Rabbits received three iv injections of 
30 mg of ATGG at two day intervals followed one day later 
with an iv injection of one ml of a 10# SRBC suspension.
The humoral immune response to SRBC was determined by both 
splenic anti-SRBC PFC on the 5th day after immunization and 
the serum hemolysin response.
Experimental group III. This experiment was de­
signed to determine the effect of HRBC priming on the hum­
oral antibody response to SRBC. These animals were treated 
as mentioned earlier (Immunization schedule for antigenic 
competition studies.). Anti-SRBC responsiveness was deter­
mined by the day 5 PFC assay and the serum hemolysin titers.
Experimental group IV. The experimental protocol 
for treatment of this group of animals is presented in Fig­
ure 3 . In order to determine the effect of ATGG treatment 
on the HRBC-induced suppression of the anti-SRBC response, 
rabbits received three iv injections of 30 mg of ATGG on 
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Figure 3. The experimental design for the study 
of the effects of ATGG-treatment on the HRBC-induced 
suppression of the anti-SRBC response.
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(day 0). The animals received one ml of 20# HRBC on day 
(-3) followed on day 0 with one ml of 10# SRBC. The effect 
of ATGG was controlled by substituting either ATGG which 
had been adsorbed with thymocytes (Adsorption of ATGG with 
thymocytes.) or NHGG for the ATGG in the above schedule.
The immune responsiveness for this experimental group and 
the controls was determined by both the day 5 splenic PFC 
assay and serum anti-SRBC hemolysin activity.
Analysis of Data
Statistical comparisons of pertinent groups were 
accomplished using the Student's t test. All p values, 
means and standard deviations from the means were obtained 
with the use of a Monroe Model 1766 calculator (Litton 
Industries, Orange, New Jersey) programmed with the 3011-S 
program.
Chapter 3
RESULTS AND DISCUSSION 
Reconstitution Studies
The first aspect of this study was directed toward 
the elucidation of the nature of the helper function of 
the T-cell during the initiation of the humoral response 
to SRBC in the rabbit.
Control group. The normal humoral antibody response 
to a single iv injection of SRBC in 8 to 10 week old rabbits 
was monitored by two immunoassay methods. One group of 13 
animals was immunized with 1.0 ml of a 10# SRBC suspension 
and seven animals were sacrificed on day five and six ani­
mals on day seven after immunization and their spleens were 
tested for direct PFC numbers. Tables 6 and 7 present the 
individual day five and day seven anti-SRBC PFC responses 
per million nucleated spleen cells and per whole spleen for 
each animal. The mean number of day seven PFC per whole 
spleen was 32,376* 20,166 and per million cells was 51- 1̂ .̂  
(Table 7). These PFC values served to represent the "normal" 
response against which the splenic PFC levels of thymecto- 
mized, x-irradiated experimental groups were compared and 
evaluated.
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Table 6.— Individual splenic plaque-forming cell responses of 8-10 week 





- — ..... —
10 spleen cells PFC per whole spleen
mean range mean range
A 66 59-73 45.990 41,000-51.030
19 82 76-91 43.000 41,000-47,500
24 54 24-78 22,680 9.996-32,800
24h4 62 51-86 45,020 36,226-68,400
36 87 72-93 58,800 48,800-66,400
37 86 68-96 41,100 31,800-48,600
38 70 61-74 55.000 49,000-62,000
mean (Is.D.) 72.4 (;±12.8) 40,214 (16,058)
Table 7.--Individual splenic plaque-forming cell responses of 8-10 week 
old rabbits 7 days after iv antigenic challenge with 1 ml of 10# SRBC
Animal
No.
PFC per 106spleen cells PFC per whole spleen
mean range mean range
455 48 36-54 22,080 16,400-24,800
454 33 25-45 33.660 25,800-46,200
466 40 22-56 15,603 8,618-22,024
471 52 45-60 68,640 59,400-78,600
49 58 50-68 15,424 13,200-17,800
41 74 71-83 38,850 35,500-41,500
mean (Is.D.) 50.8 (114.4) 32,376 (120,166)
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The mean PFC numbers on day five were 72+ 12.8 per 
10^ spleen cells and 40,21^i 16,058 per whole spleen. Day 
five was chosen as the time at which to assay spleens for 
PFC activity for the remaining experiments since the maxi­
mum effects of HRBC-induced suppression are seen at this 
time.
The SRBC hemolysin activities served as the seoond 
response parameter. Figure ** presents the mean log2 anti- 
SRBC hemolysin titers for prebleed and post immunization 
serum samples collected on days two, four, five, seven, 10, 
15, 20, 25 and 30. Sheep red blood cell hemolysin titers 
for serum samples collected through seven days from the six 
animals sacrificed for PFC data and through day 30 from six 
additional animals were determined. This response curve 
served as the normal response and was used to compare the 
hemolysin responses observed in x-irradiation, competition 
and ATGG-treated experimental groups.
Experimental groups T-X-I and T-X-BM-I. Landry 
(197*0 had previously shown that rabbits which received a 
midline x-ray dose of 900 R did not respond to SRBC immun-
Q
ization even when reconstituted with 20 x 10 allogeneic 
nucleated BM cells. One animal out of 12 in that study did 
show a significantly delayed hemolysin response which began 
on or about the l*tth day following immunization and recon­
stitution. It was speculated that this delayed response
T - X-BM-1  
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Figure k. Anti-SRBC hemolysin humoral antibody 
responses for eight to ten week old rabbits immunized 
with lxSRBC (N-I)i thymectomized, x-irradiated (900R) 
and immunized (T-X-I)» thymectomized, x-irradiated, BM 
reconstituted and immunized (T-X-BM-I), or thymectomized, 
x-irradiated, BM and thymus (cortisone-treated) reconsti­
tuted and immunized (T-X-BMT-I). Each response curve re­
presents the mean logg hemolysin titers for all rabbits 
tested.
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was the result of the differentiation of lymphoid stem 
cells present in the BM to T-cells under the influence of 
the radiation resistant epithelial structure in the thymus.
It is also possible that the thymus tissue may harbor radio­
resistant T-cells which are able to regenerate functional 
helper cells if the thymus is not removed from the experi­
mental animal (Kadish and Basch, 1975)* It thus became 
necessary to surgically remove the thymus lobes prior to 
x-irradiation in order, to avoid and/or eliminate a poten­
tial T-cell source.
Experiments were designed to determine if thymec­
tomy had any influence on SRBC responsiveness in x-irrad- 
iated rabbits which were either non-reconstituted (T-X-I)
Qor reconstituted with 20x10 nucleated littermate BM cells 
(T-X-BM-I), Table 8 shows the individual anti-SRBC PFC 
responses per million spleen cells and per whole spleen 
for thymectomized, x-irradiated (900R) immunized with 1.0 
ml of a 10% SRBC suspension after reconstitution with BM 
cells or non-reconstituted. The T-X-I group had a mean PFC 
response of 2.2t 2.6 per 10^ nucleated cells and 60+ ̂ 8 per 
whole spleen on the 5th day post immunization and the 
T-X-BM-I showed a mean PFC response of 3.0t 1.8 per 10^ cells 
and 192bt 2797 per whole spleen. The splenic PFC numbers 
for each of these experimental groups does not exceed back­
ground splenic PFC activity (7 A  per 10^ and 5»8*i4 per whole
Table 8,— Individual anti-SRBC PFC responses of 8 to 10 week old, adult 
thymectomized, Xgirradiated (900R) rabbits either reconstituted 
by using 20 x 10 nucleated BM cells (T-X-BM-I) or non-reconsti­






PFC per io6 spleen cells PFC per whole spleen
Mean range mean range
87 T-X-BM-I 1.0 0-4 356 0-1424
88 T-X-BM-I 2.1 0-8 363 0-1440
92 T-X-BM-I 5.2 2-9 6,104 2,400-10,800
57 T-X-BM-I 3.6 0-12 875 0-2,400
mean (1 S.D.) 3.0 (t 1.8) 1.924 (+ 2,797)
89 T-X-I 0.3 0-1 10 0-33
51 T-X-I 0.5 0-2 35 0-140
82 T-X-I 6.0 3-9 121 60-180
53 T-X-I 2.1 0-7 73 0-245
mdan (I S.D.) 2.2 (+ 2.6) 60 (± 48)
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spleen) for non-immunized rabbits (Landry, 197*0 •
Figure presents the log2 anti-SRBC hemolysin re­
sponse curves for these two experimental groups compared to 
the control group. The hemolysin responses reflected the 
PFC numbers in that neither group produced significant anti- 
SRBC hemolysin antibody. One animal, out of seven, in the 
T-X-BM-I group showed a delayed low hemolysin antibody re­
sponse, which could have been due either to the presence of 
residual epithelial tissue left from incomplete thymectomy 
or to the infusion of a significant population of mature 
T-cells which may have migrated to the donor bone marrow 
(Ozer and Waksman, 1972). It is also possible that the re­
sponse to SRBC is not totally a T-dependent response and 
this represents a partially T-independent response which is 
delayed and less than optimal (Miller, 1975) •
Although BM infusion did not restore immunological 
responsiveness to thymectomized, x-irradiated animals, it did 
enhance their viability. None of the non-reconstituted ani­
mals lived beyond the 7th day after x-irradiation, whereas 
three out of four of the T-X-BM-I animals which were not 
sacrificed for PFC assay lived through the 18th day, two 
beyond day 30 and one through day 75. BM infusion also re­
stored the peripheral WBC levels to near normal while counts 
in non-reconstituted animals remained severely suppressed 
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Figure 5* White blood cell counts per cu, sun. 
versus time for eight to ten week old rabbits thymectomized, 
x-irradiatedi non-reconstituted (T-X-I), reconstituted 
with 20 x 10s nucleated bone marrow cells (T-X-BM-I) or 
reconstituted with the total BM and thymus cell populations 
from cortisone treated donors (T-X-BMT-I).
stitution appeared to increase the receptiveness for allo­
geneic bone marrow cells since these animals lived longer 
and maintained higher WBC counts than did non-thymectomized 
animals treated in the same manner (Landry* 197*0. Thymec­
tomy most probably leads to the elimination of the source 
of radioresistant T-cells in the host which are responsible 
for cell mediated immunity and which could ultimately reject 
allogeneic BM cell transplants. This is supported by evi­
dence in the mouse that there is thymic regeneration in 
lethally x-irradiated animals which is independent of bone 
marrow or other stem cells (Kadish and Basch, 1975). This 
suggests that there are mature thymus cells within the thy­
mus structure which are relatively radioresistant and are 
capable of regenerating the corticomedullary lymphocyte 
population. Thymectomy with x-irradiation possibly elimin­
ate cells of host origin capable of graft rejection.
TX-BMT-I Group. Since BM alone did not success­
fully reconstitute immunological responsivenessi most prob­
ably because of the absence of a T-cell population* attempts 
were made at reconstituting thymectomized* x-irradiated rab­
bits with both BM and thymus cell populations. The addition 
of DNase to TCM 199 (used for T-cell harvesting) made thymus 
cell infusions possible. T-cell infusions in combination 
with BM from non-treated donors were only sporadically suc­
cessful in restoring immunological responsiveness. This
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marginal effectiveness could possibly be attributed to 
mature immunocompetent T-cells (10#) of the thymus with a 
relatively large number of immature cortical T-cells (90#).
A more competent T-cell population was obtained by injecting 
the donors with hydrocortisone acetate 36 hours prior to col­
lection of BM and T-cell populations. This treatment lowered 
the yield of donor thymocytes to less than 10# of what had 
been previously collected from non- hydrocortisone treated 
animals. This treatment also reduced the number of BM cells 
collected in most cases, by more than 50#. It was, therefore 
necessary to infuse each recipient with the total BM and thy­
mus cell yields from the selected treated donor litter mate.
QThe number of BM cells infused ranged from 5 x 10 to 19 x 10 
and the number of thymocytes ranged from 9 x 10  ̂to 13 x 10®.
Table 9 presents the anti-SRBC PFC responses in the 
spleens of BM and T-cell reconstituted recipients. There 
seems to be a need for a critical number of reconstituting 
T-cells as the two animals which received less than 2 x 10® 
cells (animals number 37 and 39) had PFC responses which 
were less than background! whereas, those animals which re­
ceived at least this number showed a normal PFC response 
per 10®. The mean number of PFC for animals number 33, 31,
43 and 47 per 10®spleen cells was 48+ 8.2 and 12,416+ 6,955 
per whole spleen. BM cells and thymocytes, when given in 
sufficient numbers from cortisone-treated littermate donors,
Table 9.— Individual splenic anti-SRBC PFC responses in adult thymectomized, 
x-irradiated (900R), reconstituted with the total population of BM and 
thymus cells from cortisone-treated littermate donors immunized with 









--T-------------10 spleen cells PFC per whole spleen
mean range mean range
33 2.6 9.1 40 27-52 4,800 3,240-6r240
31 12.7 18.8 43 34-48 17,350 15,300-21,600
43 5.0 12.0 58 50-70 8,352 7,200-10,080
47 12.0 5.0 52 45-60 17,160 14,850-19,800
37 0.9 9.0 7 0-14 581 0-664
39 1.0 5.2 6 0-16 780 0-1,300
Normal (N-I)* 50.8 (£ 14.4) 32,376 (± 20,166)
♦from Table 7
did synergistically restore immunological responsiveness to 
SRBC in thymectomized lethally irradiated rabbits. The ad­
dition of mature thymocytes to the reconstituting cell pop­
ulation significantly increased the PFC responsiveness of 
thymectomized lethally irradiated rabbits as statistical
£analysis yielded a p< 0.001 when comparing the PFC per 10 
of the four responding animals of the T-X-BMT-I group to 
both T-X-I and T-X-BM-I. The increase in PFC per whole 
spleen for T-X-BMT-I was also statistically significant as 
p <0.001 compared to T-X-I and p< 0.05 compared to T-X-BM-I. 
The percentage of cells in the spleens of T-X-BMT-I (recip­
ients number 31, 33» ^3 and 7̂) committed to anti-SRBC 
antibody production was not significantly different from 
that of the control group cells, as p?0.20 when comparing 
PFC/ 10^ of T-X-BMT-I with the 10^ response of the control 
group. There were, however, significantly fewer total anti- 
SRBC producing cells in the T-X-BMT-I spleens than in the 
control group spleens, p<0.10.
Figure 4 shows the mean log2 anti-SRBC response 
curve of the T-X-BMT-I group compared to that of the N-I, 
T-X-BM-I and T-X-I groups. The hemolysin response curve 
for T-X-BMT-I rabbits approached that of the control group, 
N-I. It was,however,slightly depressed and exhibited a 
longer lag period. The hemolysin titers in the T-X-BMT-I 
animals reflected the splenic PFC responses with antibody
Table 10.— Summary of the mean day 7 splenic anti-SRBC PFC responses for 
normal (N-I)i thymectomized, x-irradiated (T-X-I)i thymectomized, 
x-irradiated, bone marrow reconstituted (T-X-BM-I)i thymectomized, 
x-irradiated, bone marrow and thymus reconstituted (T-X-BMT-I)experimental groups
Experimertal Mean PFC responses
group
per 10** p values'* per whole spleen p values'*
N-I 50.8 (+ 14.4) — 32,376 (1 20,166) —
T-X-I 2.2 ( + 2.6) <0.001 60 Ct48) <0.001
T-X-BM-I 3.0 (+ 1.8) <0.001 1,924 (+ 2,797) <0.001
T-X-BMT-I3’ •05
+1(T\•00 >0.2 12,416 (+ 6,955) <0.10
£L 8represensts only those animals which received more than 2 x 10 thymus 
cells (animals number 33» 31» 43, and 47)
values represent a comparison of each group to the N-I group
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levels significantly greater than in animals reconstituted 
with BM alone.
These findings are in agreement with the results 
reported by Ozer and Waksman (1972) that there exists a re­
quirement for more than one lymphoid cell population to co­
operate and mount an immune response to SRBC in the rabbit. 
These observations also agree with the two-cell concept 
which has been reported for the mouse (Claman et al,,19661 
Miller and Mitchell, 1968) and the rat (Baum et al., 1969) 
in that T and B-cells must cooperate in order for antibody 
synthesis to occur (T-dependent antigens). It would appear 
that cortisone treatment destroys only the immature cortical 
thymocyte population in the rabbit, since T-cell helper 
function is present in cortisone treated animals. The 
functional B-cell (pre-AFC) in rabbit bone marrow apparently 
is relatively insensitive to cortisone treatment, since AFC 
activity can be restored with infusion of cortisone treated 
bone marrow.
The reconstitution studies reported here with corti­
sone treated cells in vivo confirm work done in vitro with 
cortisone treated mouse thymocytes and T-cell depleted spleen 
cells (Schimpl and Wecker, 1971). These investigators re­
ported that they were able to achieve a primary antibody 
response in vitro to SRBC with cortisone treated thymocytes 
and anti-9 serum treated spleen cells. Previous investi-
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gators were unable to use thymocytes for a T-cell source 
in the primary in vitro response due to the large number 
of immature cells. It was necessary to use a more mature 
population of T-cells (eg. thoracic duct cells). Schimpl 
and Wecker (1971) showed that cortisone-treatment selected 
for an equivalent, mature population in the thymus.
Low dose irradiation experiments. Experiments 
were designed to determine the relative radioresistance 
of thymus-derived lymphocytes. Rabbits received a mid­
line dose of 600R and then were either reconstituted with
Q20x10 littermate BM cells or served as non-reconstituted 
control animals. Both groups were prebled, immunized with 
1.0 ml of a 10# SRBC suspension and serum samples were 
taken two, four, five and seven days post immunization at 
which time the animals were sacrificed and splenic FFC 
assays were performed.
Figure 6 presents the log2 hemolysin responses de­
termined for both reconstituted and non-reconstituted animals. 
A midline irradiation dose of 600R effectivly eliminated the 
capacity of these animals to respond to a SRBC challenge, 
since the anti-SRBC hemolysin response in non-reconstituted 
animals never exceeded background antibody levels. BM cell 
infusion restored partial immunological responsiveness since 
there was a significant rise in ati-SRBC titer in BM recon­







Figure 6. Mean log2 anti-SRBC hemolysin titers 
versus time (7 day period) Tor normal rabbits immunized 
with SRBC (N-I), oOOR x-irradiated and SRBC immunized 
(X(LD)-I) and 600R x-irradiated, reconstituted with 20 
x lo8 nucleated BM cells and SRBC immunized (X(LD)-BM-I)*
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tuted animals was less than that is seen in normal animals. 
This is as would he expected since the T-cells would be of 
host origin and the B-cells would be from the donor and 
optimal cooperation might not be expected, since the coop­
eration between allogeneic T and B-cells generally does 
not compare to syngeneic cooperation.
The PFC assays in this experiment failed to yield 
any detectable plaques, probably due to some technical 
error in the assay procedure, rather than to an actual 
absence of PFC since the hemolysin responses observed in 
these animals would indicate some PFC activity.
Unfortunately, immediately following this experiment 
the rabbit colony became infected with Yersinia pseudotuber­
culosis. When "infected" animals are subjected to stress, 
such as irradiation, they rapidly succumb to the infection. 
This prevented repeating the PFC data at that time but led 
to a different experimental approach and the second aspect 
of this study. As a consequence, the low dose experiments 
were not pursued further.
The low dose experiment suggested that the T-cell 
was resistant to an irradiation dose of 600R and that the 
B-cell function was sensitive. With this in mind, the next 
series of experiments was designed to eliminate immuno­
competent B-cells with low dose irradiation and the T-cells 
by thymectomy and in vivo anti-thymocyte antibody treatment.
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It was the preliminary studies with respect to the use of 
anti-thymocyte gamma globulin as a tool for eliminating the 
T-cell helper function that led to the second aspect of this 
study.
Suppressor Function
Homogeneity of horse IgG. Figure 7 shows the im- 
munoelectrophoresis pattern for rabbit anti-whole horse ser­
um which was allowed to diffuse and react with electrophoresed 
whole serum and the OEAE chromatography IgG fraction. Immun­
oelectrophoresis of the DEAE fraction resulted in a single 
line of precipitation which had migrated toward the cathode, 
as did the IgG component of the HS, with no detectable con­
taminating components present.
Cytotoxicity indices. Each ATGG fraction prior to 
use was adjusted to give a concentration of 10 mg protein per 
ml. The dilution of the various test bleed samples taken 
from Horse 1 and 2 which gave a 50# Cl when tested against 
normal thymus cells was determined. Two horses were immun­
ized as described in the Materials and Methods, Horse 1 in 
the summer of 1973 and Horse 2 in the summer of 197̂ . It 
was found that the three week serum sample (post immuniza­
tion) for both horses yielded ATGG with the highest cytotox­
icity index. The three week serum sample for Horse 1 showed 
a 50# Cl at a 1/40 dilution* whereas, the three week sample
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Figure 7. Immunoelectrophoresis pattern for 
horse serum and for the DEAE-chromatography fraction 
(ATGG) versus rabbit anti-horse serum.
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for Horse 2 showed a 5096 Cl at a 1/32 dilution. The ATGG 
fraction from Horse 1 proved to have the greater effect 
in vivo and was used in most experiments unless otherwise 
specified. The Horse 1 serum was used in prliminary in 
vitro studies and the supply was exhausted before completion 
of the in vivo experiments. It, therefore, became necessary 
to use Horse 2 serum ATGG in later experiments.
Optimal schedule for ATGG administration. The 
following experiment was designed to determine the schedule 
for ATGG administration which was optimal for suppression 
of immunological responsiveness to SRBC. As stated above 
it was used for the intention of depleting T-cell helper 
function which is necessary for optimal immunological respon­
siveness to SRBC. Figure 8 presents the mean log2 hemoly­
sin responses for animals which received one iv injection 
of 30 mg of ATGG two days prior to SRBC immunization (IX); 
animals which received two ATGG injections (2X) one, two 
days prior and one, on the same day as SRBC immunization, 
and the 3X group which received a third injection of ATGG 
two days following immunization. Unexpectedly, all three 
ATGG treated groups showed an early response which also was 
elevated when compared to control N-I group animals through 
seven days. The apparent ATGG-enhancing effect was apparent­
ly related to the number of ATGG injections administered.
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Figure 8. Mean log2 hemolysin response curves 
for normal rabbits immunizes with lxSRBC (N-I) or for rabbits treated with 30 mg of ATGGs two days prior to 
lxSRBC immunization (IX), two days prior to and on the 
same day as lxSRBC immunization (2X), and two days prior 
to, on the same day and two days post lxSRBC immuniza­
tion (3X).
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ment and antibody levels remained elevated for a longer 
period of time than the IX or 2X groups. These findings 
suggested at least two possible means in which ATGG may 
be functioning. Either the ATGG was selectively elimin­
ating some suppressor function responsible for homeostasis 
of normal humoral responsiveness or it was acting in some 
way to enhance antibody formation. It followed that if a 
suppressor function were being eliminated or neutralized 
then ATGG might act similarly to alleviate antigen-induced 
suppression which has been observed in antigenic competi­
tion.
Antigen-induced suppression (AIS). Thome (1972) 
had previously established a competition system in rabbits 
utilizing heterologous erythrocyte antigens. She found 
that 1.0 ml of a 20% HRBC suspension (2X) injected iv opti­
mally suppressed the response to a IX (1.0 ml of a 10% sus­
pension) SRBC suspension administered three days later.
This schedule and erythrocyte immunization dose was used in 
the following experiment which utilized eight to ten week 
old rabbits. The SRBC hemolysin response of one experi­
mental group was followed through 30 days. A second group 
of six animals was sacrificed on the fifth day following 
SRBC immunization and splenic anti-SRBC and anti-HRBC PFC 
assays were done. The mean log2 anti- SRBC hemolysin re­
sponses for the AIS group are shown in Figure 11 along with
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hemolysin responses for the N-I group rabbits. The admin­
istration of a priming dose of HRBC markedly suppressed 
the hemolysin response to a subsequent SRBC challenge, 
which remained depressed through 30 days.
Table 11 presents the splenic anti-SRBC and anti- 
HRBC PFC responses for the AIS group on the fifth day 
after SRBC injection. These animals had a mean anti-SRBC 
PFC response of 29t 9.3 per million nucleated cells and 
24,342i 16,728 per whole spleen. These values are signif­
icantly depressed (p<0.001 for both groups) when compared 
to day five responses for N-I group rabbits which show 
72+ 12.8 PFC/106 and 40,214+ 16,058 PFC/whole spleen 
(Table 6 ). The mean anti-HRBC PFC numbers for the AIS 
group were 19t 5.2 per 10^ cells and 15*l67i 6,280 per whole 
spleen.
ATGG treated AIS group. Table 12 presents the anti- 
SRBC and anti-HRBC PFC responses for competition animals 
which had been treated with 30 mg of ATGG two days prior, 
the same day and two days following HRBC priming. In this 
schedule the animals received SRBC one day after the final 
ATGG injection. Half of the animals in this group were 
treated with ATGG from Horse 1 and the other half with ATGG 
from Horse 2. Both were effective in alleviating AIS al­
though the PFC values obtained for the various assays were 
somewhat different. Horse 1 ATGG showed an earlier enhance-
Table 11,--Individual splenic plaque-forming cell responses of rabbits primed 
with 2xHRBC three days prior to lxSRBC immunization (AIS) assayed on




106 spleen cells whole spleen
mean range mean range
92 40 27-46 55,300 37,800-64,400
40 26 13-34 18,000 8,400-30,400
44 30 23-38 31,500 30,000-45,600
45 33 18-51 16,250 9,000-26,000
46 13 9-17 11,200 8,000-14,400
49 35 21-51 13,800 8,400-20,400
mean(ls.D.) 29(1 9.3) 24,342(1 16,728)
00o\
Table 12.— Individual splenic PFC of rabbits primed with 2xHRBC three days 
prior to lxSRBC immunization and treated with 3xATGG (30 mg) on days 




10b spleen cells whole spleen
mean range mean range
74a 119 98-131 119,000 98,000-131,000
71a 126 88-134 190,200 132,000-201,000
7 5a 83 80-98 140,000 108,000-176,800
82b 73 67-83 26,100 23,400-30,000
83b 84 79-98 43,200 37,600-47,200
88b 57 47-62 55,500 45,000-62,000
mean (̂ S.D.) 90 ( + 26.8) 95,666 it 64,268)
Horse 1 (1973) - three week serum sample
•uHorse 2 (197*0 - three week serum sample
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mentf whereas, Horse 2 ATGG treated animals showed a more 
persistent enhanced response. The mean anti-SRBC PFC re­
sponses for these animals were 90* 26.8 per 10** spleen cells 
and 95*666- 6^,268 per whole spleen on the fifth day post 
SRBC challenge. ATGG treatment appeared to eliminate or 
neutralize the suppression induced by HRBC administration 
since these values were significantly (p< 0.001) elevated 
when compared to the non-ATGG treated AIS group. This 
group also showed a marginal increase in anti-SRBC PFC when 
compared to the non-competitive N-I response (p<0.2).
There was also an elevation in the numbers of the anti-HRBC 
splenic PFC, since the ATGG-AIS group showed PFC values of 
52* 28.0 per 10̂  and 52,283* 39*093* which represented a 
significant increase in anti-HRBC PFC responsiveness 
(p <"0.001) when compared to the AIS group.
Figure 9 shows the mean anti-SRBC log2 serum hemo­
lysin titers through 30 days for AIS group animals treated 
with the Horse 1 ATGG compared to serum hemolysin levels 
for N-I group rabbits. The hemolysin response was both ac­
celerated and elevated with a peak titer of log2 13 on day 
seven, which is significantly greater than the day seven anti 
body titer of 8.9 for the N-I group animals. The elevated he 
molysin titer dropped by the 10th day and was similar if not 
slightly depressed when compared to the N-I group through 





Figure 9. Mean log2 anti-SRBC hemolysin response 
curves for normal rabbits immunized with IxSRBC (N-I) and 
for rabbits injected with 30 mg ATGG from Horse 1 on days 
(-5)* (-3) and (-1), immunized with 2xHRBC on day (-3) and 






Figure 10. Mean log2 anti-SRBC hemolysin response 
curves for normal rabbits immunized with IxSRBC (N-l) or 
injected with 30 mg ATGG from Horse 2 on days (-5), (-3) 
and (-1), immunized with 2xHRBC on day (-3) and with IxSRBC 'g
on day (0) (ATG-AIS).
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Horse 2 ATGG treated AIS animals. In contrast to the Horse 
1 ATGG treated animals, there was no accelerated early re­
sponse in these animals. There was, however, persistent 
hemolysin production which remained elevated through day 30. 
Figure 11 compares the combined mean hemolysin response curve 
for both these groups (ATGG from Horse 1 and 2) with that of 
the non-ATGG treated AIS group and the non-competitive N-I 
group. ATGG treatment eliminated the suppressive effects 
which HRBC priming injections provoked, since subsequent 
serum hemolysin response to SRBC for ATGG-treated AIS group 
animals paralleled that of the control N-I group.
ATGG treatment followed by SRBC immunization. Figure 
12 presents the mean logg hemolysin titers for rabbits which 
received three injections of ATGG followed one day later by 
SRBC immunization. There was marked anti- SRBC hemolysin 
activity by the seventh day and the antibody titer remained 
elevated through 30 days. Splenic PFC enhancement was also 
seen for animals in this group and showed a mean PFC response 
of 120± ̂ 8.7 per 10^ cells (p < 0.05 when compared to N-I) 
and 79*2001 **9232 (p < 0.10 when compared to N-I) per whole 
spleen.
NHGG-AIS experiment. Table 13 presents the PFC 
data for AIS animals which had been treated with three in­
jections of 30 mg NHGG. The spleens of six experimental 










Figure 11. Mean log2 anti-SRBC hemolysin response 
curves for normal rabbits immunized with IxSRBC (N-I), 
primed with 2xHRBC three days prior to challenge with lx 
SRBC (AIS) or injected with 30 mg ATGG from either Horse 1 
or 2 on days (-55• (-3) and (-1), primed with 2xHRBC on day 





Figure 12. Mean log2 anti-SRBC hemolysin response vo
curves for normal rabbits immunized with IxSRBC (N-I) or ^
treated with 30 mg ATGG on days (-5)* (-3) and (-1) 
followed by IxSRBC immunization on day (0).
Table 13.— Individual anti-SRBC PFC responses of animals immunized with 
IxSRBC on day 0 after treatment with 30 mg ATGG on days (—5)•
(-3) and (-1)
 r---------------------------------Animal PFC per 10 cells PFC per whole spleen
No.
mean range mean range
251 m 163-202 124,800 111,200-137,600
265 96 87-106 45,900 42,000-51,000
270 120 102-145 31,200 26,400-37,600
252 78 68-84 31,200 27,200-33,600
253 174 126-190 141,300 108,000-171,000
254 70 66-78 100,800 95,400-111,600
mean (is.D.) 120(+48.7) 79,200 {1 49,232)
Table 14.— Individual splenic anti-SRBC PFC of rabbits treated with normal 
horse gamma globulin (NHGG) prior to the HRBC-induced suppression of 
the anti-SRBC response (NHGG-AIS).
— ----   1 — .........     r ■" ■ ■ ■'■■■ ■ “— i 1
Animal PFC per 10 cells PFC per whole spleen
No. _____________________ _________________________
mean range mean range
54 58 40-80 66,600 45,600-92,400
53 16 8-23 21,500 17,500-24,100
56 63 52-68 53*900 46,800-61,200
53A 9 6-16 7,800 4,800-15,200
57 4 3-10 4,000 2,400-9,600
59 40 33-48 32,000 26,400-38,400
mean (t s.D.) 32 (- 26) 30,966 {1 25,100)
nucleated cells and 30,966+ 25,100 per whole spleen. The 
anti-HRBC responses were 17* 19.0 PFC PER million cells and 
16,275* 17,600 PFC per whole spleen. NHGG treatment pro­
voked no significant effect ori antigen induced suppression 
of a subsequent PFC response (p >0.2) or on the anti-HRBC 
response (p ^0.2) which suggested that the active component 
in ATGG was not present in NHGG since the latter had little 
or no effect on antigen-induced suppression.
ATGG (T-adsorbed) -AIS experiment. Ninety mg ali­
quots of ATGG were adsorbed four successive times with 0.4 
ml packed cell volumes of normal rabbit thymocytes. AIS ani­
mals received three injections of "adsorbed" ATGG as previous 
ly described two days before on the same day and two days 
after HRBC injection. Adsorption with thymus cells had effec 
tively removed the anti-suppressor activity present in ATGG 
since splenic PFC numbers on the fifth day post SRBC injec­
tion were even more suppressed in the adsorbed ATGG treated 
group than in the non-ATGG-treated AIS group. The splenic 
PFC results are presented on Table 15 . Rabbits treated with 
adsorbed ATGG showed 19* 16 anti-SRBC PFC/106, 12,288+ 12,234 
anti-SRBC PFC/whole spleen, 17* 10 anti-HRBC PFC/106 and 
9»708+ 6,707 anti-HRBC PFC/whole spleen. These findings 
support the assumption that ATGG is selectively acting on 
a T-cell population responsible for suppressor activity, 
since specific Ab can be adsorbed from the ATGG fraction
Table 15.--Individual splenic anti-SRBC PFC responses of rabbits primed 
with 2xHRBC followed three days later with IxSRBC challenge and 
treated with three injections of ATGG which had been adsorbed withnormal thymocytes (ATGG-ads.-AIS)
A n i m a l P F C  per 10& c e l l s P F C  per whole spleen 
No. _____________________  _________________________
mean range mean range
1 3 1.8-3.2 1,250 900-1,600
2 4 3.2-4.0 1,480 1,280-1,600
3 46 40-51 26,800 24,000-30,600
4 17 13-23 11,400 7,800-13,800
5 30 25-32 27,900 22,500-28,800
6 15 12-18 4,900 4,100-6,300
mean S.D.) 19(^ 16) 12,288(- 12,234)
Table 16.—  Summary of the mean day 5 (after SRBC immunization) splenic 
anti-SRBC PFC responses for normal (N-I), HRBC-primed anti-SRBC 
response (AIS), ATGG treated AIS group (ATGG-AIS), NHGG treated 
AIS group (NHGG-AIS), and ATGG (thymocyte adsorbed) treated AIS
group (ATGG-ads.-AIS)
Experimental Mean PFC responses
group _______________________________________ •
per 10^ p values per whole spleen
I. N-I 72 (t 12.8) - 40,214 (i 16,058)
II. AIS 29 (J 9.3) <0.001 CMm
■3-
CM £ 16,728)
III. ATGG-AIS 90 (1 26.8) <0.2 95*666 £ 64,268)
IV. NHGG-AIS 31 (1 25.6) <0.01 30,966 £ 25,100)
V. ATGG-ads.-AIS 19 (i 16) <0.001 12,288 (± 12,234)
p values represent a comparison of the mean PFC/106 of each group 
to that of the N-I group
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with thymus cells. The first aspect of this study sug­
gested the need for a thymus cell in addition to BM in 
order for lethally x-irradiated rabbist to respond with Ab 
synthesis. The T-cell is probably functioning in the ca­
pacity of a helper cell (antigen recognition and AFC recrit- 
ment) as has been established for most other animal' systems. 
The results presented in the latter part of this study sug­
gest that in addition to helper function, there exists also 
a T-cell suppressor function which has been suggested by 
the investigations of others (Radovich and Talmage, 19671 
Gershon and Kondo, 1971a1 Okumura and Tada, 1971a,bi Arm­
strong et al., 19691 Baker et al., 1970a,b).
These results further suggest that the suppressor 
function can be assigned to a separate subpopulation of 
T-cells distinct from helper cells when viewed in the light 
of the work of others. Wu and Lance (197*0 suggested that 
the suppressor cell belongs to a subpopulation of thymus- 
derived cells which are spleen-seeking and require the 
microenvironment of the spleen for expression. Scavulli 
and Dutton (1975) separated the two populations (suppressor 
and helper) based on their variable susceptibility to Con A 
stimulation and x-irradiation sensitivity. They found the 
suppressor cell to be susceptible to complement-mediated 
lysis in the presence of specific anti-thymocyte serum. 
Weksler et al. (197*0 reported that suppressor activity was
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sensitive to cortisone in contrast to cortisone-resistant 
helper cells. In opposition to Scavulli and Dutton and the 
present study they reported that suppressor activity was 
resistant to the action of anti-thymocyte antiserum.
Most investigators have reported that in vivo admin­
istration of ALS or ATS suppressed the humoral response to 
subsequent injections of SRBC and other T- dependent Ag 
(Lance, 1973i Baum et ai.,19691 James, 19691 Kerbel and 
Eidinger, 1971)* Others have reported that ALS treatment 
has little effect on the humoral response to T-dependent Ag 
(Baker et al., 1970| James, 1969s Stewart and Bell, 1970) 
and in some instances their data, if closely examined, suggest 
a slight enhancement in the humoral Ab response. This var­
iability in the reported effect of anti-thymocyte antibody 
does suggest that there is a difference in the anti-sera 
preparations and that there may be antigenic as well as 
functional differences between helper and suppressor cell 
populations. It is possible that certain preparations of 
anti-thymocyte antisera are directed primarily toward one 
population of T-cells or the other, possibly dependent upon 
their relative concentrations in the immunizing doses or 
preparations. It is highly likely that there is antibody 
activity directed against both suppressor and helper cells.
If the action of the antisera (anti-thymus) is being assayed 
in a T-dependent Ag system, such as SRBC, then the anti­
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suppressor activity would not be apparent, since the helper 
activity necessary for Ab expression would also be elimi­
nated or destroyed with the suppressor activity. This con­
clusion was supported by the observations of Baum et al. 
(I969) and Baker et al. (1970) who reported consistent en­
hancement of Ab synthesis in mice to specific T-independent 
Ag (Streptococcus pneumonia SSS III) when treated in vivo by 
the administration of ALS.
The enhanced response to the T-dependent Ag, SRBC, 
with ATGG observed in this study suggests that this antiserum 
preparation is directed primarily toward the suppressor func­
tion. The effect of the ATGG can be attributed to the elim­
ination of a suppressor function rather than a stimulatory 
influence on T-cell helper function since horse ATGG is cap­
able of eliminating the suppression observed in antigenic 
competition. Treatment with ATGG must leave helper function 
more or less intact in order to allow the response observed. 
These results suggest antigenic differences between the two 
subpopulations. Whether these differences reflect the pres­
ence of distinct haptenic determinants on each thymic cell 
subpopulation or rather, relative variations in concentra­
tions of shared determinants can not be determined from the 
data at this time.
Some investigators have suggested that helper and 
suppressor functions are immunological expressions of the
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same cell, and it is suggested that the T-cell acts in­
itially in a helper capacity and as the immune response 
progresses, the T-cell switches to a suppressor function.
If this were so then it would seem likely that anti- T-cell 
antibodies would not be effective in eliminating suppressor 
activity unless they were administered after the initiation 
of the helper activity. The fact that in this study en­
hancement was observed even when ATGG treatment preceded 
antigenic stimulation suggests that the suppressor precur­
sor cells exist as a separate population independent of 
antigenic stimulation.
In conclusion, these results suggest the existence 
of T-suppressor cells responsible for the antigen-induced 
suppression observed in antigenic competition. This ob­
served suppression may be a manifestation of a homeostatic 
function of the suppressor T-cell which keeps the immune 
response within proper limits and rather conservative, since 
enhancement was observed with elimination of suppressor 
function (especially with Horse 1 ATGG) when the animals 
received only a single antigen, SRBC. This regulatory func­
tion of the T-cell extends to control of responses to T- 
independent antigens and to cell mediated immunity as well.
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